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CHAPTER 1 
 
AN INTRODUCTION TO TRANSITION METAL HOMEOSTASIS 
 
All living organisms are maintained by constant chemical processes which 
require many of the elements of the periodic table. Metals play different roles in 
living systems (1). Organisms have evolved to make use of the special properties 
of metals to perform many important functions. Some of these are for biological 
signaling processes, charge maintenance, structural roles, electron transfer, 
enzyme catalysis, dioxygen transport (2-3). The metal ions are made available to 
the organisms by various methods depending upon the surrounding conditions; 
these elements can be made bioavailable or the organisms accumulate the 
necessary nutrients by several processes.  
Table 1.1. The Composition of some common elements in the human body(2). 
ELEMENT PERCENTAGE(by weight) 
Sodium, Potassium, Sulfur 0.1 
Chlorine 0.09 
Silicon, Magnesium 0.04 
Iron, Fluorine 0.005 
Zinc 0.003 
Copper, Bromine 2 X 10-4 
Selenium, Manganese, Arsenic, Nickel 2 X 10-5 
Lead, Cobalt 9 X 10-6 
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1.1 INORGANIC PHYSIOLOGY 
Living cells constantly acquire, store and transport metal ions such that 
the optimal concentrations of these metals are readily available for 
metalloproteins and also to protect themselves from the toxic effects of metal 
excess (3). The optimal concentrations of different metals can vary widely. The 
concentration of calcium is very high in the human body and its major use is the 
stabilization of the endoskeleton (2). Also are present large amounts of 
potassium, sodium and magnesium which function to maintain charge and 
osmotic balance or as structural elements (2). These elements belong to Groups 
I and II of the periodic table and are called macro nutrients (2, 4). Some 
elements like iron, zinc, copper, molybdenum, cobalt, chromium, vanadium and 
nickel are less abundant. These transition metals are called trace metals (2). 
Iron, copper, zinc, cobalt, and nickel are essential for organisms and play several 
important biological roles. Iron is involved in dioxygen transport in hemoglobin 
and myoglobin and in electron transfer (2, 4) . Copper serves as an electron 
carrier in cytochrome c oxidase, as a facilitator of oxygen transport in 
hemocyanin, and also as a catalytic site for enzymes such as superoxide 
dismutase (2, 4). Zinc functions as a structural element in zinc finger proteins; it 
plays a regulatory role (in superoxide dismutase) and catalytic roles in several 
enzymes. Cobalt serves in alkyl group transfer in Vitamin B12 and oxidases (2). 
Nickel is involved in nitrogen fixation, oxo transfer in oxidases, and plays a 
catalytic role in hydrogenases and hydrolases (2, 4). 
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  Studies in bacterial cells have shown that they maintain transition metal 
ions in a fixed and narrow range; this is represented as the total number of metal 
atoms per cell, and this value is called the metal quota (5).  E.coli, for instance 
concentrates transition metal ions down to a narrow range as follows: iron and 
zinc (~0.1mM), and copper, manganese, molybdenum and selenium (~ 0.01mM) 
(6). Other metal ions such as sodium, potassium and magnesium are highly 
abundant in bacterial cells (~10mM) (6). Some toxic metals like cadmium, 
mercury, lead are also found in organisms but do not have any specific or known 
biological role. For this reason, metal ion concentrations have to be very tightly 
controlled since they are essential for survival but at the same time any change 
in concentration can cause havoc. Essential transition metal levels in a cell have 
to be precisely regulated such that there is a sufficient supply of the metal, at the 
same time an excess of essential and the non essential metals must be avoided 
since it would lead to metal toxicity. This process of maintaining the 
concentration of essential metal ions in the right concentration range is called 
homeostasis, and detoxification or resistance is the removal of toxic 
concentrations of non essential metal ions (7). All organisms have to maintain 
metal homeostasis for survival.  
1.2 Cellular Metal Homeostasis 
Metal ion regulation is a very important cellular function performed in 
unison by several proteins: metallochaperones, metalloregulators and metal 
transporters (8). These proteins are involved in the tightly regulated processes of 
uptake, storage and secretion. Two decades ago, the discovery of the genes 
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responsible for Wilsons, Menkes, and Lou Gehrig’s diseases threw light on 
cellular metal homeostasis mechanisms (9). Wilsons disease is an autosomal 
recessive disorder characterized by the accumulation of toxic amounts of copper 
in the liver, kidney and brain (10). ATP7B, a 1411 – amino acid copper 
transporting ATPase, is the gene responsible for this disease; it is located on 
chromosome 13 (10). Menkes disease is an X-linked disorder characterized by a 
deficiency of copper and is caused by defects in the ATP7A gene (11). Both 
these proteins are involved in copper transport. Some other proteins which were 
subsequently studied were transferrin that transports iron into the cell, its 
counterpart being ferritin which is involved in iron efflux (11). Studies on the 
Wilsons and Menkes proteins and similar proteins in several organisms have 
lead to models showing how chaperones, sensors and transporters work towards 
metal delivery, and positioning metals in the required location in the cell. 
1.2.1 Metallochaperones 
Metallochaperones are helper proteins which bind to metal ions and 
transfer them to the target proteins (12).Copper, nickel and iron chaperones are 
well documented. Examples of chaperone proteins are Atx1 which is the first 
copper chaperone to have been identified in S.cerevisiae; the human homolog of 
this protein is Atox1 which transfers copper to the Menkes and Wilsons disease 
proteins (9).The bacterial homolog of Atox1 and Atx1 is CopZ in E.coli which 
interacts with CopA and CopY (9, 12). CCS is a copper chaperone for 
superoxide dismutase which inserts copper directly into the target protein (12). 
So far only two known iron chaperones have been documented in literature. 
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Frataxin, a protein implicated in a neurological disease Friedreich’s ataxia, is a 
mitochondrial iron chaperone (13). Human poly(rc) binding protein 1 (PCPB1) is 
a cytosolic iron chaperone that binds to iron and loads ferritin (13). The nickel 
chaperone UreE delivers the metal to the active site of the enzyme Urease (14). 
Chaperone proteins for very few metals are known, so it is thought that most 
proteins get their metals from the cytoplasmic metal pools. But then, how do the 
cells sense the need for metal ions? 
1.2.2 Metal Sensors 
Metal sensors are transcriptional regulators; they detect and respond to 
metal deficiency or excess in the cells. There are several bacterial sensors which 
have been identified they are classified as metal de-repressors, co-repressors 
and metal activators (15). ArsR-SmtB, CsoR-RcnR and CopY are some of the 
metal de-repressors and Fur, NikR and DtxR are co-repressors, and MerR is an 
example of an activator (15). 
1.2.3 Metal Sequestering Proteins 
Cells can control the transport of metal ions but at the same time they can 
also control the free metal ion concentrations with the help of metal sequestering 
proteins. The example of Metallothionein illustrates the role of a metal 
sequestering protein. It  participates in the process of sequestering metals such 
as zinc and thus serves as a reservoir for zinc ions (16). In addition to zinc, 
metallothionein can also bind to cadmium, and lead. Metallothionein is a cysteine 
rich protein that can bind to seven zinc ions in two zinc/thiolate clusters. In one 
cluster, three zinc ions are bound to nine cysteines (Zn3S9) and the other has 
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four zinc bound to eleven cysteines (Zn4S11) (16). In these clusters, zinc is in a 
tetrahedral coordination environment with the sulfurs (16). The different zinc ions 
bind to metallothionein with a range of affinities. Cadmium also binds to 
metallothionein with four coordinate geometry. Unlike zinc and cadmium, 
metallothionein binds to lead in trigonal geometry (17). 
1.2.4 Transcriptional and Translational metal regulation 
Metal regulatory transcription factor (MTF1) genes are induced in 
response to metals such as copper, cadmium and zinc. Studies have reported 
that zinc stabilizes a complex between MTF1 and its DNA binding site (15). The 
Drosophila MTF1 has a copper cluster and zinc fingers, the cysteine residues 
that coordinate the cluster when replaced by alanine do not upregulate the 
transcription of copper metallothionein gene in response to a high concentration 
of copper (15). Also are present several proteins that control translation or 
mRNA stability for different gene products. Some examples are the iron 
responsive proteins IRP1 and IRP2; they bind to iron responsive elements in 
mRNAs that encode ferritin and transferring receptor. Ferritin is required when 
there is excess iron and transferrin is needed when there is low amount of iron 
(15). 
1.2.5 Post translational metal regulation 
Degradation of proteins involved in metal homeostasis is a way of post 
translational metal regulation; this applies to several proteins such as the iron 
responsive protein IRP2, the copper chaperone CCS, the copper importer CTR1,  
the iron efflux protein ferroportin and  the zinc uptake transporter ZIP4 (15). ZIP4 
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is a good example to explain the phenomenon of post translational metal 
regulation. When zinc is low, the extracellular amino terminal domain of ZIP4 
undergoes proteolytical degradation (15). When zinc is absent ZIP4 is removed 
from the plasma membrane to a perinuclear location and when zinc is very high 
ZIP4 is degraded. ZIP4 has a histidine rich motif that is responsible for 
ubiquitination and proteolytic degradation (15). This motif also responds to 
cadmium by triggering degradation. 
1.2.6 Metal transporters 
Metal transporters are important members of the metal trafficking 
machinery. The uptake and efflux transporters are expressed under decreased 
and high metal conditions, respectively. Some of the transporters at the 
cytoplasmic membrane are ABC (ATP-binding cassette)-type ATPases, P-type 
ATPases, cation diffusion facilitator proteins, NRAMPs (natural resistance 
associated with macrophage protein) and ZIPs (Zrt /Irt – like protein) (18). The 
ABC transporters and the P-type ATPases utilize the energy from ATP hydrolysis 
to pump metal ions. ABC transporters are uptake pumps, they import 
manganese, zinc, nickel and iron across the cell membrane (18). These pumps 
work in unison with proteins located in the periplasm. P-type ATPases are efflux 
pumps that export a wide variety of metals. The CDF proteins export ions from 
the cytoplasm, through a coupled transport of two ions in the opposite direction 
(18). Nramp is a large family of proton coupled transporters that have roles in 
uptake of iron and manganese (18). Mammalian members of the ZIP family of 
proteins have been identified. 
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Thus, metallochaperones, metal sensing proteins and metal transporters 
together play an important role in regulating the intracellular transition metal 
concentration and helping cell survival.  
1.2.7 Examples of how these metalloproteins regulate copper and iron 
homeostasis 
Copper homeostasis 
In mammals, copper is absorbed from the gastrointestinal tract by a P-
type copper transporting ATPase, ATP7A (Menkes protein) (19). Cu+ is then 
transported into the cell by the human copper transporter(hCTR1), and from here 
is further delivered to other targets by other copper chaperone proteins like 
Atox1, Ccs1, Cox17 and glutathione for delivery to Wilsons protein (ATP7B), 
superoxide dismutase, cytochrome oxidase, and metallothionein (19-20). ATP7B 
then transports copper to the luminal side of the secretory network (19).  
Iron homeostasis 
Like copper, iron is another vital metal that is required for the formation of 
hemoglobin and myoglobin; it helps maintain a healthy immune system (21). The 
iron homeostasis machinery mainly involves transferrin, iron that is absorbed is 
bound to transferrin (22). Transferrin receptors assist transferrin in shuttling the 
iron to cellular targets. Some other proteins involved in iron homeostasis are 
DMT1(divalent metal transporter1), ferroportin, ceruloplasmin, Nramp2 (21-22). 
Unlike the copper and iron metabolism and homeostasis, which have 
been well studied and documented, very little is known about the uptake and 
storage of other metal ions. In the pursuit of understanding the details of other 
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metal homeostasis, our lab over the years has worked on metal transporters and 
my research over the past few years has focused on a zinc efflux pump in E.coli 
– the zinc transporting ATPase, ZntA. 
1.3 Chemistry of Transition Metals 
Transition metal ions in cells are found chelated to proteins or cofactors; 
the common metal ligands are O, N, S, or C. Within the cell there are present a 
large number of non specific binding sites for metals, thus it is  truly a challenge 
to accommodate each metalloprotein with the correct metal ion (14). How does 
nature distinguish between the different transition metal ions and maintain a 
balance of ions? In order to understand this phenomenon one must first be 
familiar with the Irving-William series (the natural order of stability for divalent 
transition metals) and also the chemical properties of transition metals. 
1.3.1 Irving-William series 
In the complex cellular environment, as per the Irving-William series 
copper and zinc form the tightest complexes, then nickel and cobalt, then ferrous 
iron and manganese and finally the weakest complexes are formed by calcium 
and magnesium (Mg2+< Ca2+ <Mn2+  <Fe2+ <Co2+ <Ni2+ <Cu2+ >Zn2+) (14) . But 
within the same cell some proteins bind to uncompetitive metals and some 
proteins bind to competitive metal ions. How do the proteins distinguish the 
wrong metals from the right ones? Cells overcome the problem imposed by the 
Irving-William series by compartmentalization and this was recently 
demonstrated by two periplasmic proteins in cyanobacteria, MncA for 
manganese and CucA for copper (23). Manganese and copper are at the 
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opposite ends of the Irving-William series, and both proteins prefer to bind to 
copper in vitro. The concentration of manganese in the cytoplasm is ~10 µM and 
that of copper is in the pM range (4). The MncA protein is a substrate for Tat 
(twin-arginine translocase) which helps MncA to fold in the cytoplasm to trap 
manganese; now MncA is folded and the metal binding site is buried inside the 
protein (23). On the other hand CucA is a substrate for Sec (general secretory 
pathway) which enables the CucA to fold in the periplasm after export thus 
binding to the competitive copper (23). Thus MncA and CucA can exist together 
and manganese cannot be replaced by the competitive copper. 
1.3.2 Chemical Properties of Metals 
Transition metals are involved with many different metalloproteins. Most of these 
transition metals have more than one oxidation state. Some oxidation states are 
more common than the others. They also display different geometry and 
coordination which may govern metal selectivity and specificity. 
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Table 1.2. Chemical Properties of Transition Metals (2). 
Oxidation State Coordination 
Number 
Geometry 
Iron(II), d6 4-6 Tetrahedral, Octahedral 
Iron(III),d5 3-8 Trigonal, Tetrahedral, Square planar, 
Trigonal bipyramidal, Octahedral 
Cobalt(I),d8 6 Octahedral 
Cobalt(II),d7 4,6 Tetrahedral, Octahedral 
Cobalt(III),(d6) 6 Octahedral 
Nickel(II),d8 4,6 Square planar, Octahedral 
Copper(I), d10 3,4 Trigonal planar, Tetrahedral 
Cu(II),d9 3-6 Trigonal planar, Tetrahedral, Square 
pyramid, Tetragonal, Square planar 
Zinc(II),d10 4-6 Tetrahedral, Square pyramid, 
Octahedral 
 
Knowledge of the chemical properties of non essential metal ions like cadmium, 
lead and mercury is very useful in understanding how these metals mimic 
essential metal ions leading to toxic side effects. 
 
 
 
 
12 
Table 1.3. Chemical Properties of some Non Essential Metals (2). 
Oxidation State Coordination 
Number 
Geometry 
Cadmium(II), d10 4,6 Tetrahedral, Octahedral 
Lead(II),d10 3-6 Trigonal, Pyramidal, Square planar, 
Octahedral 
Mercury(II),d10 2 Linear 
 
1.4 Background on Zinc 
Zinc is the most common transition metal ion in the cytoplasm, but it is not 
as prevalent as group 1 and 2 metal ions (4). Zinc, which is essential for cell 
survival, serves as a cofactor for many enzymes. It plays a structural role as a 
scaffold for RNA polymerase, and tRNA synthetases (24). Zinc inhibits free 
radical formation and thus protects sulfhydryl groups. When the cellular 
concentration of zinc increases it has toxic effects; it blocks thiols and prevents 
disulfide bond formation and binding of other metals to their active sites (18, 24-
25).  
1.4.1 Chemistry of Zinc 
Zinc has an outer electronic configuration of 3d104s2. Zinc is a very small 
ion (radius 0.65Å) and has a very concentrated charge to size ratio (4). It is also 
a good electron acceptor or Lewis acid, and its electron affinity is similar to 
copper and nickel (4). These metal ions bind to donors such as thiolates and 
amines with a high affinity. However, zinc does differ from copper and nickel in 
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its oxidation state (4). Both copper and nickel display multiple oxidation states. 
This redox inertness of zinc is perhaps a reason why it is a preferred metal ion in 
several biological reactions since redox activity introduces the risk of free radical 
formation (4). In addition to small size, high charge density and redox inertness, 
it also displays both hard and soft metal character. Zinc uses sulfur, oxygen and 
nitrogen as ligands in biological systems (17). Cys, His, Asp, and Glu are the 
most common amino acid ligands in zinc proteins. The coordination geometries 
preferred by zinc in biology are tetrahedral and trigonal bipyramidal (2). The 
diverse properties and flexible nature of zinc may explain why it is the only metal 
being represented in all six recognized classes of enzymes (17). The properties 
that make zinc valuable in biology relative to other metals are its availability, fast 
ligand exchange, redox inertness, flexible coordination geometry, good Lewis 
acid properties, and intermediate soft metal character; these are all put to 
particular uses in the cell.  
1.4.2 Biology of Zinc 
Zinc bound to proteins can play both structural and catalytic roles. Two 
well known zinc metalloproteins are Cu/Zn superoxide dismutase and alcohol 
dehydrogenase (Adh1). These are examples of high affinity zinc sites; low affinity 
zinc binding sites are present on proteins, lipids, and DNA and amino acids 
(histidine), glutathione and organic anions (citrate) (26). Since zinc is an integral 
part of so many proteins and reactions, the amount of free zinc in the cell must 
be very low. The term “free” is used to specify the labile zinc that is freely 
available for participating in reactions (26). Studies suggest that the total amount 
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of zinc present in the cell is in the millimolar range (6, 26). Many of the zinc 
metalloproteins have very high binding affinities, 1 nM zinc is equivalent to about 
30 zinc ions per yeast cell and about 300 ions in a mammalian cell (26). 
Interestingly, free zinc is much lower in concentration (femtomolar range) despite 
the total amount of zinc being so much higher (6, 26-27). This underscores the 
perfect regulation of free zinc inside the cell and the delicate balance between 
zinc uptake, efflux, and sequestration.  
Zinc regulators induce or repress specific operons or genes. These gene 
products are involved in zinc transport. In E.coli two zinc sensors Zur and ZntR 
have affinities in the femtomolar range for zinc which is much lower than the 
concentration of zinc in the cell (26-27). When the cell is zinc deficient, the Zur 
regulatory protein which is a member of the Fur family of bacterial metal 
responsive regulators, induces the expression of uptake transporters such as 
ZnuABC and ZupT (17, 26). Once the uptake stops, the accumulated zinc is 
used by the zinc proteins or the excess is exported out of the cell. ZntR which 
belongs to the MerR family of transcriptional regulators, induces the efflux 
transporter ZntA (17).  
1.5 Transport systems for zinc 
Transporters are a major component of the zinc homeostasis machinery. 
The import of zinc and its transport out of the cell requires several membrane 
transport proteins. Zinc transport proteins belong to several families: some of 
them are ZIP proteins, ABC transporters, RND transporters, P-type ATPases, 
and CDF proteins (26, 28). 
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The ZIP proteins [(Zrt/Irt-like protein) ZIP (SLC39) family] 
  The first identified members of this family were the yeast Zrt1 and the 
Arabidopsis Irt1 proteins. Mammalian ZIP proteins have been designated as 
SLC39 (26, 28). The ZIP proteins have 8 transmembrane domains (29). Many 
proteins that belong to this family have a histidine rich loop located between the 
3rd and 4th transmembrane domains which maybe involved in zinc binding (29). 
The mechanism of transport used by ZIPs is still not very clear. Zrt1 in yeast 
uses energy to transport zinc, whereas the human Zip2 (SLC39A2) is not energy 
dependent (29). Studies show that zinc uptake by the mammalian transporter 
may be due the HCO3 gradient across the cell membrane (26). 
The ABC transporter family 
This is a diverse group of active membrane transporters. Members of this 
group mediate a variety of transport processes in both prokaryotes and 
eukaryotes. They play a role in maintaining metal homeostasis by importing 
metal ions such as zinc; in addition they are also involved in the uptake of 
nutrients, resistance to cytotoxic drugs and antibiotics, and cholesterol and lipid 
trafficking (26). ABC transporters are a complex of three proteins, one or two of 
them being membrane embedded (30). These proteins form a pore in the 
membrane that permits the transport of specific substrates (28). Energy of ATP 
hydrolysis is used to transport substrate across the membrane (28). 
The CDF proteins 
The mammalian members of the cation diffusion facilitator (CDF) family 
are called ZnT (SLC30) (26). CDF transporters are present bacteria, fungi, plants 
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and mammals. Most members of this family have six transmembrane domains 
(26, 28). The CDF proteins also have a histidine rich cytoplasmic loop between 
transmembrane domains 4 and 5. Many CDF proteins transport metals by 
antiport (Zn2+/H+ or K+) (26). 
The RND (Resistance-Nodulation-Division) family 
An example of the RND family is the CzcABC protein in Ralstonia 
metallidurans. The CzcD protein  is induced under high Zn2+ concentrations (31). 
CzcA, CzcB and CzcC form a complex system that exports Zn2+, Co2+ and Cd2+ 
across the cytoplasmic and outer membrane. CzcA is a cation–proton antiporter 
that is located in the cytoplasmic membrane (31). CzcB is located in the 
periplasm. CzcC connects CzcB to the outer membrane to form CzcABC protein 
complex (31). 
Other Efflux Transporters 
Zinc efflux transporters mediate the export of intracellular zinc to avoid the 
over accumulation of zinc and thus protects the cell from toxic side effects of zinc 
overload. In mammalian cells, Znt1/SLC30A1 which belongs to the CDF family 
plays a role in zinc efflux to maintain cellular zinc homeostasis and trans-
epithelial zinc trafficking (26). In the brain, the zinc efflux transporters are very 
important after an ischemia or epileptic seizures as there is high accumulation of 
zinc (32). Yeast is different from other eukaryotes; it does not have any zinc 
efflux systems but the excess zinc is sequestered into vacuoles and this is a site 
for detoxification (26).  
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1.6 Zinc homeostasis in E.coli 
E.coli is a very good model system to study zinc transporters. Our lab has 
for several years used E.coli transporters as model systems to characterize 
metal transporters. E.coli has a zinc quota of ~ 105 atoms of zinc per cell (6, 26). 
E.coli has both high and low affinity transporters that work together to maintain 
cellular zinc homeostasis.   
Broad Spectrum Zinc uptake transporter in E.coli 
When the zinc concentration in an E.coli cell is within the normal range, a 
broad substrate transporter ZupT is induced. ZupT is the first characterized 
bacterial uptake pump that belongs to the ZIP family of proteins (33). ZupT has 
eight transmembrane helices and studies have shown that ZupT is involved in 
the uptake of several ions such as Zn2+,Fe2+,Co2+,Cd2+ and Mn2+(33-34). The 
energy source and the mechanism of transport are not clear.  
High affinity Zinc uptake pump in E.coli 
When zinc concentrations are extremely low, the E.coli operon znuABC is 
induced by Zur. The ATP dependent uptake of zinc is catalyzed by ZnuABC. 
This pump depends on ZnuA which is a periplasmic binding protein having the 
ability to bind metal ions and ATP (18). ZnuB is the membrane permease and 
ZnuC is the subunit that catalyses ATP hydrolysis (18).  
Low Affinity zinc Efflux transporter in E.coli 
Unlike the transporters involved in zinc uptake, the zinc export proteins 
have more specific substrates. Here too, there are high affinity and low affinity 
systems. ZitB (YbgR) a member of the CDF family is a low affinity zinc efflux 
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transporter (18). Sequence analysis and site directed mutagenesis studies 
suggest several residues such as His53, His159, Asp163 and Asp186 are 
essential for function (18). It has been observed that these residues are 
conserved in other CDF proteins even though the metal transported may vary 
suggesting that these residues may form a proton channel (17). 
High Affinity Zinc Efflux transporter in E.coli 
In E.coli, when there is an over accumulation of zinc, ZntR a zinc sensor 
activates the expression of an active transporter ZntA (Zinc transporting ATPase) 
which is a high affinity pump that is involved in zinc efflux (28). ZntA belongs to 
the P-type ATPase family of transporters. These are a class of ion pumps that 
are involved in many biological processes such as generating membrane 
potential, muscle contraction, removal of toxic ions from cells. 
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Figure 1.1. Zinc Homeostasis in E.coli. 
1.7 P-type ATPases 
In 1950’s Jens Skou discovered the first P-type pump, the Na+/K+ ATPase 
that uses ATP to transport Na+ and K+ ions across the axonal membrane (35). 
Through the years many other pumps with similar characteristics have been 
discovered such as the gastric H+/K+ ATPase and the sarcoplasmic-reticulum 
Ca2+ ATPase that plays an important role in muscle contraction. A common 
feature of this class of transporters is the formation of a phosphorylated 
intermediate during the reaction cycle (36). The Ca2+-ATPase, Na+/K+ ATPase, 
H+/K+ ATPase are very well studied and documented. Studies on these pumps 
have revealed several interesting details about the structure and mechanism of 
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this family of transporters. All the members of the P-type ATPase family have 
four well-defined domains. 
The Phosphorylation (P) domain 
This domain contains the DKTGTLT motif, which is conserved throughout 
the P-type ATPase family. The Asp in this motif gets phosphorylated reversibly 
during the reaction. The P-domain in Ca2+ ATPase is roughly spherical and has a 
Rossman fold with a central seven stranded β-sheet flanked by α-helices 
(37).This domain is homologous to bacterial ATPases (36). 
The Nucleotide (N) domain 
As the name suggests it is here that ATP binds. The N-domain is a part of 
the P-domain. In the Ca2+ ATPase it is a β-sheet made of seven strands. The N-
domain of Na+/K+ ATPase has a similar fold as the Ca2+ ATPase except that the 
β-sheet is made up of six and not seven strands  (37).  
The Actuator (A) domain 
The sequence of this domain like the P-domain is highly conserved. It 
contains the conserved TGES motif. This domain is not involved in metal 
binding. Structural studies indicate that this domain has a β-sheet jelly roll fold 
which contains many conserved residues. This domain and especially the 
conserved TGES motif comes in close contact with the phosphorylation domain 
when the ion is being pumped (37). 
The Membrane (M) domain 
The membrane domain consists of six to ten membrane helices 
depending on the P-type ATPase family. The Ca2+- ATPase and Na+/K+ ATPase 
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have 10 transmembrane helices (38). On comparing the sequences of the 
membrane region of various ATPases they were found to have very little 
sequence homology. However the overall structure of this region is similar. In the 
SR- Ca2+-ATPase, Asp800 in M6 and Glu805 in M8 provide ligands for Ca2+ 
binding (37). The corresponding sites involved in ion translocation in N.crassa H+ 
ATPase are Asp730 and Glu 805, and in A.thaliana H+- ATPase, it is Asp 684 
(39). In addition to these, Val304, Ala305 and Ile307 in M4 are also involved in 
binding Ca2+ (37). 
 
Figure 1.2. The Post-Albers Cycle based on the Na+/K+ ATPase. 
The ion 1 from the interior of the cell binds to the high affinity site in the ATPase 
which is the E1 state. Ion binding triggers phosphorylation of the enzyme by 
Mg2+-ATP, which leads to the phosphorylated E1-P state. The phosphorylated 
E2-P state then forms, which is unable to phosphorylate ADP, and this state has 
Inside Outside 
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a reduced affinity for ion 1, and it goes outside the cell. Ion 2 binds from the 
outside and, on hydrolysis of the phosphorylated Asp, the enzyme releases ion 2 
to the interior and rebinds ions 1. The enzyme is ready to start another cycle. 
                
 
Figure 1.3. E1.2Ca2+ and E2 (TG)2 forms of Ca2+ ATPase in the lipid bilayer, 
generated by molecular dynamics simulation (37). E1.2Ca2+ is the high affinity 
state when the two calcium ions from the interior of the cell are bound to the 
ATPase in the E1 state. Ion binding triggers the phosphorylation of the ATPase, 
this leads to formation of the E2-P state, which is unable to phosphorylate ADP 
and has low affinity for the metal ion.  In the figure, the cylinders represent the α-
helices, arrows β-strands.  
 
Ca2+ ATPase is about 150 Å high and 80 Å thick, it is made up of a cytoplasmic 
head piece, a transmembrane domain which has 10 α-helices (M1-M10), and 
small luminal loops (40). Helices M2, M3, M4 and M5 have long cytoplasmic 
extensions (37, 40). The cytoplasmic headpiece is made up of the Actuator, 
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Nucleotide binding and Phosphorylation domains. In the Ca2+ ATPase the A 
domain controls the gating mechanism that in turn controls the Ca2+ binding and 
release (37). The N domain contains the ATP binding site. In the phosphorylation 
domain, the Ɣ-phosphate reacts with the Asp351 (37). In the E1.Ca2+, the A, N 
and P domains are wide apart. A domain is connected to helices M1 – M3, and P 
domain to helices M4 and M5. Helix M5 is very long, it functions as the backbone 
of the molecule (37). The SR Ca2+ ATPase has two high affinity Ca2+ binding 
sites in the transmembrane region (indicated by two purple circles in figure1.3). 
When the two Ca2+ ion dissociate to form the E2 state, the three domains which 
were wide apart come close together to form a compact structure (37). P domain 
inclines 30˚ with respect to the membrane, N domain rotates 60˚ with respect to 
the P domain and A domain shifts 110˚ horizontally (37). In the E2 state, helices 
M1, M3 and M5 are bent (37). Helices M1-M6 undergo major changes involving 
rearrangement (37). Thus, dissociation of Ca2+ ions leads to change in position 
of P domain which in turn leads to structural changes in the membrane region. 
All P-type ATPases follow the same reaction mechanism. The 
Phosphorylation and Actuator domains all function in a similar manner. It is the 
N-terminal and the membrane domains that are involved in metal binding, 
depending of the class of ATPase their metal ion selectivity changes. Thus each 
ATPase has evolved to accommodate metal ions having different size and 
geometry (36). 
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1.8 Classification of P-type ATPases 
On the basis of sequence alignment and substrate specificity this family is 
classified into five groups (group’s I-V). Each group is further divided into 
subgroups on the basis of substrate specificity (36, 41).  
Type IA ATPases 
This is a class of bacterial pumps, the E.coli Kdp K+- pump is an example of this 
group. Kdp is made up of four different proteins – KdpF, KdpA, KdpB and KdpC. 
KdpB is the ATPase that pumps K+ ions and it has six membrane helices (42-
43).  
Type IB ATPase  
These transporters were discovered much later. They are simpler in terms 
of evolution especially the bacterial pumps. These ATPases are very 
widespread, and are present from archea to man. This group of ATPases has 
very broad substrate specificity; they are soft transition metal ions. Some of the 
examples of this class are the bacterial metal resistance proteins such as CopA, 
ZntA and CadA. These pumps assist in maintaining homeostasis of essential 
metal ions such as Cu+ or Zn2+ which may be toxic when they are in excess and 
also remove toxic ions such as Ag+, Cd2+ and Pb2+ from the cell thus maintaining 
the homeostasis of essential ions (36, 44-46). 
Type II and Type III ATPases 
The previously mentioned sarcoplasmic reticular Ca2+- ATPase, and the Na +/K+ 
ATPase belong to Type II and the H+ ATPase is an example of class III.  
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Type IV and V 
Both type IV and V are groups of transporters which are not as well researched 
as the other classes of P-type ATPases. Type IV ATPases are found in 
eukaryotes, where they are involved in lipid transport and maintenance of lipid 
bilayer asymmetry (36). They are also known as lipid flippases. Studies in the 
red blood cell and S.cerevisiae have shown that these flippases translocate 
phospholipids from the outer to the inner leaflet of plasma membranes (36). 
These proteins have similar features as the metal ion transporting P-type 
ATPases. The type V family of transporters has features similar to other P-type 
ATPases, however their substrate specificities and biological roles are yet to be 
studied (36).  
1.9 Classification of PIB ATPases 
The Zinc Transporting ATPase (ZntA) was identified by our lab in 1997. 
ZntA belongs to the P1B family of ATPases. The discovery that the mutations in 
Cu+ ATPases were responsible for Menkes and Wilsons disease first drew 
attention to this class of pumps in 1993. The widespread presence of these 
pumps from archea to humans speaks of the important roles these proteins play 
in maintaining metal homeostasis. All the members of this class have 8 
transmembrane regions. Helix 6 shows the characteristic CPC motif which is 
involved in metal binding (47). Based on the differences in their sequences and 
the metal ions they transport, they have been classified into several subgroups.  
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Subgroup IB-1 
Some of the well studied and characterized proteins such as the Menkes 
and Wilsons disease proteins belong to this group. Studies have shown that 
these are Cu+ ATPases that transport Cu+ out of the cytoplasm. These pumps 
can also transport Ag+ (48-49). These proteins have several metal binding 
domains (0-6) in the N-terminal region. 
Subgroup IB-2 
ZntA belongs to this group. This subgroup of proteins consists of proteins 
that drive the efflux of divalent metals such as Zn2+/Cd2+/Pb2+. Some of the 
proteins that belong to this class include Synechocystis ZiaA, E.coli ZntA, 
S.aureus CadA (50-52). The P1B2 type proteins have been found in archea, 
prokaryotes and plants. Both P1B1 and P1B2 have a CPC motif in helix 6 but 
distinct sequences in H7 and H8, which differentiates the two groups. 
Subgroup IB-3 
CopB from E.hirae was the first characterized P-IB3 type ATPase. 
Sequence analysis shows that members of this group have a conserved CPH 
motif in transmembrane helix 6 and also a histidine rich N-terminal metal binding 
domain (47). CopB was originally characterized as a Cu+/Ag+ ATPase, but later 
studies showed it to be predominantly activated by Cu2+ transport and partially 
activated by Cu+ and Ag+ (45, 53). 
Subgroup IB-4 
Sequence analysis using membrane prediction software has speculated 
that members of this group have only six transmembrane helices with only four 
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domains in the N-terminal half of the proteins and two domains downstream of 
the characteristic P-type ATPase cytoplasmic loop; however, there has been no 
experimental demonstration of this (47). These proteins do not have the N-
terminal metal binding domain. Studies on Synechocystis PCC6803 CoaT, a 
member of this group have shown that this protein maybe involved in Co2+ 
transport (47). 
Subgroup IB-5 and Subgroup IB-6 
Very few members of these groups have been characterized. Their 
substrate specificities and residues that participate in metal coordination are not 
known (45, 47). 
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Group IB-1: Cu+/Ag+                 Group IB-2:Zn2+/Pb2+/Cd2+ 
         
      Group IB-3: Cu2+/Cu+/Ag+             Group IB-4: Co2+?             Group IB-5? 
Figure 1.4. The metal specificity and structural characteristics of each subgroup. 
1.10 Background on ZntA 
 ZntA a P-type ATPase is induced by ZntR, which exports not only Zn2+, 
but also Pb2+ and Cd2+. ZntA homologues are present in bacteria, archea and 
plants. Early studies in our lab have shown that a zntA knock out strain results in 
sensitivity to zinc, lead and cadmium (54). This knock out strain did not show any 
sensitivity to copper and silver, indicating that in vivo ZntA is very specific for 
divalent metal ions (54). Purified ZntA is activated in the presence of Zn2+, Pb2+, 
Cd2+ and also Hg2+(50). ATPase activity is highest in the presence of lead. Other 
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divalent metals such as Cu2+, Ni2+ and Co2+ also weakly activate the pump. ZntA 
has two high affinity metal binding sites one in the hydrophilic N-terminal domain 
and the other in the transmembrane region (55).  
 
Figure 1.5. Schematic representation of ZntA showing the different domains and 
the conserved residues. 
 
Studies on a truncated form of ZntA called ∆N-ZntA which lacks the cytoplasmic 
N-terminal loop have shown that this truncated protein possesses in vitro activity 
although the activity is 2-3 fold lower than wild type ZntA for Pb2+, Cd2+ and 
Zn2+(56). ∆N-ZntA cloned into ZntA knock out strain when grown in media that 
has toxic concentrations of Pb2+, Zn2+ and Cd2+ was able to grow thus providing 
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resistance to these metal ions. However, when compared to ZntA the growth rate 
was rather slow (57). Stoichiometry measurements by ICP-MS have shown that 
∆N-ZntA can bind to only a single metal ion and the metal binding affinity is 
similar to the other metal binding site (56). Thus, although the N-terminal domain 
is not necessary for the overall activity of the protein it does provide a kinetic 
advantage to the enzyme. The N-terminal cytoplasmic region of proteins in the 
IB2 subgroup is about 100 residues long. 
 
Figure 1.6. Alignments of the N-terminal domain of members of subgroup P1B-2. 
 
Most of these proteins that belong to P1B2 group have a hydrophilic cytoplasmic 
metal binding domain containing one to many copies of a metal binding motif 
CXXC. ZntA, in addition to the CXXC motif has an upstream conserved motif 
which is CCCDXXC. In the Menkes and Wilsons disease proteins six copies of 
the CXXC motif are present (58). Studies on the N-terminal domain of the 
Menkes and Wilsons disease related proteins have shown that they can bind to 
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many metal ions (59). Solution structure of part of the N-terminal region of ZntA 
(residues 46-118) comparing the apo and zinc bound forms have shown that 
they have βαββαββ-ferredoxin like fold which is very similar to that of copper 
chaperones and to the N-terminal soluble domains of Cu+ ATPases (60). Zn2+ 
binds to the two cysteines and aspartate of the GMDCXXC motif with tetrahedral 
coordination (5). Structural and biochemical data on similar proteins from other 
laboratories have shown that presence of different residues changes the metal 
selectivity pattern (53, 59, 61). 
Biochemical studies in the past have indicated that lead binding to the N-
terminus of ZntA requires more than the two cysteines of CXXC; some cysteines 
from the upstream CCCDXXC motif may be involved in conferring high selectivity 
to lead (56). The N-terminal domain is involved in binding to different metal ions 
and when it is absent the activity of the transporter is reduced, indicating that it 
may have other functions. 
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Figure 1.7. Solution structures of the N-terminal metal binding domains of 
L.monocytogenes CadA, E.coli ZntA and B.subtilis CopA. Metal ligands are in 
yellow, highly conserved residues in red, and the van der Waals contacts 
involving some hydrophobic residues are shown in blue (60). 
 
The Transmembrane region of ZntA 
Unlike other groups of the P-type ATPase family, members of P1B group 
to which ZntA belongs have a smaller number of transmembrane helices and a 
smaller ATP binding loop. ZntA is a much simpler transporter when compared to 
the Ca2+ ATPase or the Na+/K+ ATPase where 2 metals are bound in the 
transmembrane region. ZntA has 8 transmembrane helices. The transmembrane 
region is essential for the activity of ZntA and one metal binding site is located 
here. Sequence analysis studies have shown that helices 6, 7 and 8 of ZntA 
have conserved residues which may be involved in metal binding and catalysis.  
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Figure 1.8. Alignments of H6 of ZntA and its close homologues. 
 
Figure 1.9. Alignment of H7 and H8 of ZntA and its close homologues. 
 
Helix 6 in all P1B type ATPases has a conserved motif, [C/S/T] P[C/H] (X) 
4[X/T] XP (figure 1.8). Sequence analysis studies suggest that transmembrane 
helices 6, 7 and 8 have conserved residues which may play a role in metal 
selectivity.  For example, transporters selective for Cu+/Ag+, Zn2+, Pb2+, and Cd2+ 
have a CPC motif in the sixth helix whereas other ATPases that are selective for 
Co2+ or Cu2+ have a conserved SPC and CPH motif (figure1.4) (47, 55). 
Mutational studies on the cysteine residues in ZntA from E.coli and CopA from A. 
fulgidus have shown that when the cysteines were replaced by other amino acid 
residues this leads to complete loss in ATPase activity (47). Studies on the CPC 
motif in our laboratory have shown that mutations at each of the cysteines 
resulted in loss of ATPase activity and the mutants were unable to bind to metal 
ions (55). Mutational studies also indicated that the two Cysteines are essential 
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for Pb2+ binding. Serine and Histidine substitutions at these residues did not 
affect binding of Zn2+ and Cd2+ but the mutants were unable to confer resistance 
to toxic levels of Zn2+ and Cd2+ (55). ZntA and its close homologues that are 
selective for divalent metal ions have a conserved aspartate residue in helix 8 in 
addition to the CPC motif. None of the other subgroups of the  PIB family have a 
conserved acidic residue at this position (62). These studies indicate that metal 
selectivity is achieved by choosing metal ligands that result in high binding 
affinity and also optimal binding geometry. 
In helices 7 and 8, there is a single conserved Asn residue at the 
cytoplasmic ends of these two helices (figure 1.9). However, sequence analysis 
of the P2 and P3 ATPases indicated the presence of a conserved Asp residue in 
helix 6, which corresponds to helix 8 in ZntA. Mutations of the Asp800 and 
Asp826 from Ca2+ ATPase SERCA1 (P2 ATPase) and Na+/K+ ATPase lead to 
complete loss in activity (62) .  
     Ca2+ ATPase   EALIPVQLLWVNLVTDGLPATALGFNPPDLD 815 
     Na+/K+ ATPase LPLGTITILCIDLGTDMVPAISLAYEAAESD 841 
ZntA         TTLLGMTGLWLAVLADTGATVLVTANALRLL 732 
Figure 1.10.  Alignments of H8 of ZntA compared to Helix 6 of Ca2+ ATPase and 
Na+/K+ ATPase. 
X-ray crystallographic studies on SERCA1 have shown that Asp acts as a 
bridging ligand to both the Ca2+ ions in the membrane. Studies on Asp714 in 
ZntA performed in our laboratory have shown that this residue in addition to the 
CPC motif is a ligand for metal ions, any substitution at this site leads to 
complete loss in enzyme activity (62). Biochemical studies indicate that lead 
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binding at the transmembrane site involves Asp, and the two Cys but it is slightly 
different from Zn2+ and Cd2+ (62). The transmembrane metal binding site like the 
N-terminal site binds to different metal ions (Cu2+, Ni2+, Co2+) with high affinity 
(63). These studies indicate that conserved residues in the transmembrane 
helices contribute to metal specificity and selectivity through correct metal 
coordination and geometry. 
Table 1.4. Hard –Soft Acid - Base Classification of Metal Ions and Ligands (2). 
Metals Geometry Ligands 
 
Zn2+ 
Intermediate 
Tetrahedral, Square 
pyramidal 
 
O-Carboxylate, 
Carbonyl, 
S-thiolate, Thioether 
N-imidazole 
 
Pb2+ soft 
Trigonal, Square Planar, 
Octahedral 
 
Sulfur ligands in 
RSH, RS-, R2S, S-
Thiolate, Thioether, 
N-imidazole, 
O-Carboxylate 
 
Cd2+ soft 
 
Tetrahedral, Octahedral 
 
 
           Ag+ soft Linear, Planar, 
Tetrahedral 
            
Cu+ soft 
Linear, Trigonal, 
Tetrahedral, Octahedral 
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1.11 Lead and Cadmium 
Cadmium and lead are not essential for organisms. But these metals do 
enter the cells by unknown pathways. Studies have suggested that both 
cadmium and lead due to similarities with many of the physiologically relevant 
metals can compete with these and lead to harmful effects. Lead and cadmium 
both have a very high affinity for soft Lewis bases (2). There is a lot of literature 
on lead toxicity, unfortunately very little is known about the biochemical 
mechanisms or the lead efflux models. ZntA confers resistance and is activated 
by Pb2+ < Zn2+ < Cd2+, however it does not confer any resistance to Ag+ and Hg2+ 
but these metals do activate the transporter (50). When the chemical properties 
of these metal ions are compared they have several differences.  
Over the past several years all the research on ZntA  point to a single fact 
that metal selectivity is not a function of metal affinity to the binding site rather 
the preferred geometry and coordination to the sites and also the change in 
conformation of the protein due to metal binding.  
1.12 Aims of the thesis 
The major goal of the research presented here has been to study the 
structural and biochemical aspects of ZntA which will give us an insight into the 
different mechanisms adopted by metal transporting proteins to achieve metal 
selectivity. Characterization of conserved cysteine residues in the cytoplasmic N-
terminal domain of ZntA and the interaction of this domain with the core 
transporter has been presented in this thesis. 
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In the first part, research on conserved cysteine and aspartate residues in 
the N-terminal domain and their role in metal binding is presented. This 
cytoplasmic loop has two cysteine clusters –CCCDXXC- and -GMDCXXC-, 
previous studies in our lab have shown that both these cysteine motifs are 
required for Pb2+ binding but not Cd2+ and Zn2+ (56). ZntA  has two metal binding 
sites, one in the membrane region and the other in the N-terminal region and 
both are involved in binding Pb2+,Cd2+,Zn2+,Cu2+,Co2+ and Ni2+ with similar affinity 
(56). These observations indicate that certain residues from both the motifs may 
be involved in contributing to metal selectivity and, in addition, these residues 
may also play a role in regulating metal binding geometry and coordination. In 
this study, the individual cysteine residues were altered to alanines and the 
individual aspartate residues were altered to alanine and asparagine in both the 
full length ZntA and in the N-terminal fragment. The effect of these mutations on 
the activity of the transporter and metal binding has been described in Chapter 2. 
My research also focuses on elucidating the interaction between the N-
terminal domain and the membrane domain. Earlier experiments showed that a 
mutant of ZntA which lacks the N-terminal domain, ∆N-ZntA, was able to grow in 
the presence of Pb2+, Zn2+ and Cd2+ but the growth rate was slower than ZntA. 
This indicates that the presence  of the N-terminal domain confers an in vivo  
growth advantage on ZntA (56). ∆N-ZntA is active in vitro but the activity is 2-3 
fold lower than the full length protein, indicating that the N-terminal portion is not 
essential for the in vitro activity of the protein but it does provide a kinetic 
advantage to the transporter (56). Studies on other P1B type ATPases, such as 
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CopA from E.coli suggest the N-terminal domain may interact with metal 
chaperones or may be involved in copper regulated trafficking of copper pumps 
from intracellular compartments to the plasma membrane (49). Recent studies 
on CopA from A.fulgius have shown CopZ, a Cu+ chaperone, delivers Cu+ to the 
Cu+ ATPase transmembrane metal binding sites (64). The cytoplasmic metal 
binding domain of CopA does not perform this function of metal delivery but it 
plays a regulatory role (64). So far no zinc chaperone proteins have been found, 
so the important question is how does ZntA get its metal?  Our theory, that the 
N-terminal domain binds to the metal ion from the cytoplasm and then passes it 
to the metal binding site in the transmembrane region, is supported by the results 
in the past from ∆N-ZntA, and a site-directed double mutant, C59A/C62A-ZntA. 
In this section, the ATPase activity of the transporter was measured in the 
presence of N-terminal domain (N1-ZntA) bound to metal as the substrate in 
order to determine the catalytic rate at which N1-ZntA bound metal can activate 
the transporter. Metal transfer was also measured by transport assays. 
Fluorescence energy transfer measurements were performed to study the 
interaction between N1-ZntA and ∆N. Chapter 3 of the thesis focuses on an 
ongoing project in the laboratory, which involves a characterizing a truncated 
form ZntA(Del231-ZntA), which lacks the amino terminal domain and the first 
four transmembrane helices. This protein has the conserved CPC motif and Asp 
residue which are involved in metal binding. The in vivo resistance profile, 
ATPase activity of the transporter and the metal binding stoichiometry have been 
examined to investigate effect of loss of the first four transmembrane helices on 
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metal selectivity.  The work presented in Chapter 4 is work in progress; the 
characterization of the truncated form of ZntA which lacks the first four 
transmembrane helices is described.  
1.13 Significance of the thesis 
Transition metals play innumerable roles in biological systems. They are 
essential in several cellular reactions, they may be involved in catalysis by being 
a part of enzymes, and they also play an active role in stabilizing structures of 
proteins and nucleic acids, thus regulating several downstream biological 
pathways. But at the same time they and heavy metal ions can have toxic effects 
on cells because when these metal ions are in excess they can bind and react 
with several cellular components leading to undesirable consequences. To avoid 
these ill effects, organisms have evolved several mechanisms to regulate the 
homeostasis by uptake or elimination of essential ions such as iron, copper and 
zinc and nonessential ions such as cadmium, lead, mercury and silver (65-66). 
There has been an immense amount of research on iron and copper 
homeostasis systems for several years. Zinc is unique unlike iron and copper it 
does not display any redox activity. It is the second most abundant transition 
metal which is associated with several zinc binding proteins (4). There are 
several zinc transporters, ZIP family, CDF family (Zit’s, ZnT’s) and the ABC 
transporters in mammals. But not much is known of the metal binding, 
coordination, geometry and ion selectivity of these transporters. ZntA is a very 
good model protein to study the above roles as it is not only a zinc transporter 
but it also plays a role in the transport of heavy metals such as lead and 
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cadmium which are extremely toxic to cells.  Results presented here are of 
significance because they give us an indication of the residues that contribute to 
ion selectivity and coordination geometry, and also describe the role of 
cytoplasmic N-terminal domain in kinetics, metal binding and transfer. These 
results can be used as a basis to explain mechanisms of transition and heavy 
metal binding and transport in several proteins involved in metal trafficking. 
These studies pave the way in understanding other metalloproteins; metal 
transport and trafficking are accomplished by proteins that display bioinorganic 
chemistry which is not similar to any of the other well documented 
metalloenzymes. The knowledge gained by elucidating the mechanism by which 
ZntA functions gives us an insight into how metal transporters work in many 
diseases such as Alzheimer’s, Parkinson’s, Acrodermatitis enteropathica, 
diabetes, asthma and certain kinds of cancers. Details of metal transporters in 
these diseases may provide insights for development of drugs against the above 
mentioned diseases. 
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CHAPTER 2 
CONSERVED MOTIFS IN THE AMINO –TERMINAL DOMAIN OF ZNTA: 
THEIR ROLE IN METAL BINDING AND SELECTIVITY OF THE PUMP 
The N-terminal domain of ZntA (N1-ZntA) has residues which fall into two 
classes: those that are conserved in subgroups 1 and 2 of PIB-type ATPases and 
those that are only conserved in closely related homologues of ZntA. My goal 
has been to identify the role of these residues in metal binding and also in 
providing metal specificity. 
2.1 Introduction 
Transition metal ions are vital for cellular function and survival. Organisms 
have several proteins that maintain metal homeostasis, which are located in the 
cytosol, mitochondria and cell surface. One such class of proteins is the P1B 
ATPases; these are integral membrane proteins that transport heavy metals 
across cell membranes (36). This class of proteins is present in bacteria, yeasts, 
nematodes, and mammals. On the basis of sequence homology and substrate 
specificity this family has been classified in subgroups for example: PIB-1 which is 
specific for monovalent metal ions like Cu+ and Ag+ and PIB-2 which transport, 
divalent soft metal ions Zn2+, Cd2+ and Pb2+ (45). ZntA from E.coli and CadA from 
S.aureus are representative members of this second group. The reasons behind 
this metal selectivity and specificity in the PIB family of transporters are not well 
understood, though structural and biochemical studies have provided some 
details in this regard. The cytoplasmic N-terminal region of both PIB-1 and PIB-2 
transporters have the conserved cysteine rich motif (CXXC) (47); this CXXC 
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motif is also present in some copper chaperone proteins and in the bacterial 
periplasmic mercury binding protein MerP. The Menkes protein ATP7B contains 
six copies of the CXXC motif, which are involved in binding copper and thus 
translocating it to the lumen. Proteins such as Atx1 and Ccc2, which play a role 
in copper delivery also have the CXXC motif (12). Structural studies of the Atx1, 
Ccc2, CopZ and MerP have shown that these proteins share a similar ferredoxin-
like (β1-α1-β2-β3-α2-β4) fold (8, 67). Solution structures of part of N1-ZntA 
(residues 46-118), comparing the apo and zinc bound forms have shown that it 
has a βαββαββ-ferredoxin like fold which is very similar to that of copper 
chaperones and to the N-terminal soluble domains of Cu+ ATPases and MerP 
(5). Another NMR study has shown that in pumps that transport Zn2+ and Cd2+, 
these metal ions are bound in tetrahedral co-ordination to two cysteine residues 
and the carboxylate oxygens of a conserved aspartic or glutamic acid residue. 
Sequence analysis of the PIB pumps have shown that the conserved motif is 
DCXXC or CXXC with a conserved D/E suggesting that an acidic residue is 
necessary for conferring divalent metal ion selectivity (60). In addition to the 
DCXXC sequence, ZntA and its close homologues from Salmonella typhi and 
Klebsiella pneumoniae also have an upstream cysteine rich motif CCCDXXC in 
the N-terminal domain (56). Studies in our lab had suggested that  this motif is 
required for binding  lead at the N-terminal site in ZntA, and that this motif is 
present in pumps that are highly selective for lead (56). Data have shown that 
the membrane domain (∆N-ZntA), which lacks the N-terminal domain, has 2-3 
fold lower activity  than wtZntA for Pb2+, Cd2+ and Zn2+ (56, 68). It has been 
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suggested that the N1-ZntA is not necessary for the overall activity of the protein 
but it provides a kinetic advantage to the protein (68). Stoichiometry 
measurements by ICP-MS have shown that the isolated domain, N1-ZntA, binds 
to lead, zinc, cadmium, copper, nickel and cobalt with a stoichiometry of 1. 
Additionally another construct N2-ZntA, where the first 46 residues were deleted 
was constructed. N2-ZntA bound to zinc and cadmium with similar stoichiometry 
as N1-ZntA but N2-ZntA was unable to bind to lead (56).  
M.tuberculosis -------------------------------------------------------MGCECSSCS 9 
S.aureus       -------------------------------------MSEQKVKLMEEEMNVYRVQGFTCANCA 27 
H.pylori       -------------------------------------------------MQEYHIHNLDCPDCA 15 
B.Subtilis     ---------------------------------------------MRLVKQEYVLDGLDCSNCA 19 
S.typhi        -MSTPDTDGKKVPPFTSFRLAPAIQKADSCCCEEHCASSAPVSTAVAGTRYTWKISGMSCAACA 63 
ZntA           -MSTPDNHGKKAPQFAAFKPLTTVQNANDCCCDGACSSTPTLSENVSGTRYSWKVSGMDCAACA 63 
 
M.tuberculosis -------PSGN-------------------------------------------GNEILVMAAS 23 
S.aureus       -------GKFEKNVKKIPGVQDAKVNFGASKIDVYGNASVEELEKAGAFENLKVSPEKLANQTI 84 
H.pylori       -------SKLERDLNELDYVKKAQINFSTSKLFLDTSDFE--------------KVKAFIKQNE 58 
B.Subtilis     ----NCARKIENGVKGIKGINGCAVNFAASTLTVSADGKEE--------QWVTNKVEKKVKSID 68 
S.typhi        ----------RKVENAVRQIRGVNQAQVLFATEKLVVDADTDLRAQIEHAVQKAGYTLRSEDS 110 
    E.coli        -----RKVENAVRQLAGVNQVQVLFATEKLVVDADN------------DIRAQVESALQKAGYS 110 
Figure 2.1. Alignments of the N-terminal domain of members of P1B-2 group. 
In this study, the importance of each individual cysteine residue, as well 
as the aspartate residues, in the two cysteine-rich motifs in metal ion binding and 
conferring metal selectivity was examined. The effect of alanine and/or 
asparagine substitutions on metal binding and in vivo and in vitro activity was 
evaluated. Individual alanine mutations at Cys31, Asp32, Cys35, Asp58, Cys59 
and Cys62 had reduced ATPase activities and they also lost the ability to bind 
lead and cadmium ions. The profile of these mutants for zinc was interesting; 
none of the substitutions bound to zinc ion, additionally these mutants exhibited 
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lower in vivo and in vitro activity when compared to wtZntA. To understand the 
co-ordination environment of lead, zinc and cadmium, and obtain details 
regarding ligand environment and geometry, the technique of X-ray Absorption 
Spectroscopy (XAS) was used. The XAS experiment and analysis were 
performed in collaboration with Dr.James Penner Hahn at University of Michigan.  
2.2 Materials 
Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained from 
Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the 
ATPase activity assay and standard metal solutions were purchased from 
Sigma. Metal standards used for inductively coupled plasma mass spectrometry 
(ICP-MS) were from VWR. 
2.3 Experimental Methods 
2.3.1 Construction of N1-ZntA with carboxyl - terminal strep tag 
N1-ZntA(residues 1-111 of ZntA followed by a eight residue strep tag) was 
created by PCR using the plasmid pZntA as template and the oligonucleotides 
5’-CTA CTG TTT CTC CAT ACC C 3’ as forward primer and 5’ GCG CTC GAG 
TTA TTT TTC GAA CTG CGG GTG GCT CCA CAG GGA ATA GCC TGC 3’ as 
the reverse primer. The amplified PCR product was cloned into pET16b using 
Nco1 and Xho1 sites; this was then transformed into E.coli strains TG1 and Bl21. 
2.3.2 Construction of C29A, C30A, C31A, D32A, D32N, C35A, D58A, D58N, 
C59A, C62A  
In order, to identify the residues involved in metal binding sites, several 
point mutations were created. All these mutants were created in ZntA using the 
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quick change site directed mutagenesis kit and the following nucleotides were 
used: C29A - 5’ AAC GCC AAC GAC GCA TGC TGC GAC GGC 3’ and 5’ GCC 
GTC GCA GCA TGC GTC GTT GGC GTT C 3’; C30A - 5’ AAC GCC AAC GAC 
TGC GCA TGC GAC GGC GC 3’ and 5’ GCG CCG TCG CAT GCG CAG TCG 
TTG GCG TTC 3’; C31A - 5’ AAC GAC TGT TGC GCT GAC GGC GCC TGT 
TCC 3’ and 5’ GGA ACA GGC GCC GTC AGC GCA ACA GTC GTT 3’; D32A – 
5’ AAC GAC TGT TGC TGC GCC GGC GCA TGT TCC 3’ and 5’ GGA ACA 
TGC GCC GGC GCA ACA GTC GTT 3’; D32N - 5’ AAC GAC TGT TGC AAC 
GGC GCC TGT TCC -3’ and 5’ GGA ACA GGC GCC GTT GCA GCA ACA GTC 
GTT-3’; C35A – 5’ TGC GAC GGC GCA GCT AGC AGC ACG CCA AC 3’ and 5’ 
AGT TGG CGT GCT GCT AGC TGC GCC GTC GC 3’ ; D58A – 5’ GTC AGC 
GGC ATG GCA TGC GCC GCC TGT GC 3’ and 5’ GCA CAG GCG GCG CAT 
GCC ATG CCG CTG AC 3’; D58N – 5’ GTC AGC GGC ATG AAT TGC GCA 
GCC TGT GCG 3’ and 5’ CGC ACA GGC TGC GCA ATT CAT GCC GCT GAC 
3’, C59A – 5’ GTC AGC GGC ATG GAC GCC GCG GCC TGT GCG CGC 3’ and 
5’ GCG CGC ACA GGC CGC GGC GTC CAT GCC GCT GAC 3’ ; C62A – 5’ 
GGC ATG GAC TGC GCC GCG GCT GCG CGC AAG GTA G 3’ and 5’ CTA 
CCT TGC GCG CAG CCG CGG CGC AGT CCA TGC C 3’. The altered bases 
for the mutations are indicated in red. The QuikChange mutagenesis is a 4 step 
procedure, where the oligonucleotide primers, each complementary to the 
opposite strands of the vector, are extended during temperature cycling by Pfu 
\Turbo DNA polymerase. Following temperature cycling the amplified DNA is 
then treated with Dpn1 which digests the parental DNA template. The amplified 
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and Dpn digested DNA is then transformed into XL1-Blue supercompetant cells. 
Colonies were picked and plasmids purified and checked by digestion with the 
corresponding restriction enzyme. The plasmids were also verified by automated 
DNA sequencing (WSU). The mutant genes were cloned in pBAD-mycHis C 
vector from Invitrogen and expressed in strain LMG194 (zntA::cat), this strain is a 
zntA knock out strain. All these mutants were created in the full length construct 
with a C-terminal His tag (50). 
These mutants were also created in the N1-ZntA fragment. The mutant 
ZntA plasmid was used as template and the pBAD-75 (5’-ATA AGA TTA GCG 
GAT CCT-3’) and ZntA-N1strepreverse (5’-GCG CTC GAG TTA TTT TTC GAA 
CTG CGG GTG GCT CCA CAG GGC ATA GCC TGC-3’) as the 
oligonucleotides for PCR. The PCR product and pET16B were digested using 
Nco1 and Xho1. Following restriction digestion the pET16B and the amplified 
DNA were ligated together to generate the plasmid N1-ZntA with the mutation. 
The N1-ZntA was inframe with strep tag at the C-terminus.  The sequence was 
verified by automated DNA sequencing at WSU.  
2.3.3 Protein expression and Purification of the ZntA mutants 
 The His-tagged full length ZntA mutants were expressed by growing 
LMG194 (zntA::cat) cells transformed with the appropriate plasmid at 37˚C 
overnight for about 15 hrs in ZY medium (supplemented with 0.5% glycerol, 
0.05% glucose, 0.2% alpha lactose, 1mM MgSO4) followed by induction with 
0.2% arabinose. Cells were harvested after 15 hrs of growth, washed with ice-
cold buffer containing 25mM Tris, pH 7.0 and 100mM KCl, and cell pellets were 
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stored at -20˚C. Protein purification procedures were all performed at 4˚C. 
Frozen cells were thawed and resuspended in buffer A (25 mM Tris, pH 7.0, 100 
mM sucrose, 1 mM PMSF, 1 mM EDTA and 1 mM β-mercaptoethanol (BME)) at 
0.2g/ml. The cells were broken at 20,000 p.s.i using a French press; the lysed 
cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30 min. 
The lysed cells were then centrifuged at 8000 rpm for 30min. The supernatant 
was then centrifuged at 40,000 rpm for 1 h to separate the membranes from the 
soluble fraction of cells. The pellet from this centrifugation was resuspended in 
buffer B (1 mM Tris pH 7.0, 100 mM sucrose, 1 mM EDTA, 1 mM PMSF, and 1 
mM BME), stirred for 1 h at 4˚C, and then it was centrifuged at 40,000 rpm for 1 
h. The membrane was then resuspended in buffer C (25 mM Tris pH 7.0, 100 
mM sucrose, 500 mM NaCl, 1 mM PMSF and 1 mM BME). Triton-X-100 was 
added to a final concentration of 1% and the suspension was stirred for 1 h at 
4˚C. The solublized membranes were then centrifuged at 40,000 rpm for 1 h to 
remove the insoluble fraction. The supernatant was then loaded on a charged 
Ni2+-pro-bond column. The column was washed successively with buffer C, 
buffer C + 50 mM imidazole, and buffer C + 100 mM imidazole. Finally the 
protein was eluted using 30 ml of buffer C with 300 mM imidazole. 1 ml fractions 
were collected and analyzed for protein. Protein containing fractions were pooled 
and loaded on 40 ml Sephadex G-25 columns to remove imidazole. Protein 
fractions were collected and concentrated using YM-100 centricons. The protein 
was stored at -80˚C with 10 % glycerol as a cryoprotectant.  
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2.3.4 Protein expression and purification of N1-ZntA and N1-ZntA mutants 
The strep tagged N1-ZntA was expressed by growing the N1-ZntA 
transformed BL21DE3plysS strain at 37˚C in Luria Bertani medium 
supplemented with 100µg/ml ampicillin until the absorbance at 600 nm was 0.8. 
This was followed by induction with 0.1 mM IPTG and then the temperature was 
lowered to 30˚C. Cells were harvested 4 h after induction, washed with ice-cold 
buffer containing 25 mM Tris, pH 7.0 and 100 mM KCl, and cell pellets were 
stored at -20˚C.The strep tag is a short peptide (8 amino acids, WSHPQFEK), 
which binds with high selectivity to Streptactin, an engineered streptavidin. The 
frozen cell pellets were thawed and resuspended in buffer A (100 mM Tris pH 
7.0, 150 mM NaCl, and 1 mM EDTA). The cells were broken at 20,000 p.s.i, the 
lysed cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30 
min. The lysed cells were then centrifuged at 8000 rpm for 30 min. The 
supernatant was then centrifuged at 40,000 rpm for 1 h to separate the 
membranes from the soluble fraction of cells. The supernatant was loaded onto 
a 5ml streptactin Sepharose column (IBA Technologies). The column was 
washed with 5 bed volumes of buffer A, and then the protein was eluted using 6 
times 0.5 column volume buffer A + 2.5 mM desthiobiotin. 1ml fractions were 
collected and analyzed for protein. Protein containing fractions were pooled and 
loaded on 40 ml Sephadex G-25 columns which were pre-equilibrated with buffer 
B (10 mM Bis Tris pH 7.0 and 150 mM KCl) to remove desthiobiotin and EDTA. 
Protein fractions were collected and concentrated using YM-3 centricons. The 
protein was stored at -80˚C with 10 % glycerol as a cryoprotectant.  
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2.3.5 Determination of Protein Concentration 
Protein concentrations were determined by Bichinchonic acid assay, using 
bovine serum albumin as standard. In this assay the proteins reduce Cu2+ to Cu+ 
in a concentration dependent manner. Bichinchonic acid forms a purple complex 
with Cu+, which has an absorbance maximum at 562 nm. This absorbance is 
proportional to the protein concentration. BSA is used to generate a standard 
curve. 
2.3.6 ATPase Activity Measurements 
The activity of ZntA and the ZntA mutants was measured by a coupled 
spectroscopic assay, involving pyruvate kinase and lactate dehydrogenase. The 
regeneration of ATP is coupled to the oxidation of NADH, which is monitored at 
340 nm (50). The buffer for the reaction was 0.05 M Bis tris, 0.1 M acetic acid, 
and 0.05 M triethanolamine at pH 7.0. The reaction mixture (1ml) also contained 
0.1% asolectin, 0.2% Triton–X–100, 10% glycerol, 5 mM ATP, 0.25 mM NADH, 
1.25 mM phosphoenolpyruvate, 7 units of pyruvate kinase, and 10 units of 
lactate dehydrogenase, with or without metal ion (Zn2+,Pb2+,Cd2+). The proteins 
were reduced by incubation with 2 mM DTT for 1 h prior to the reaction. About 
0.5-2mg/ml protein was used per assay. The reaction mixture was incubated for 
5 min at 37˚C before initiating the reaction with 5 mM MgCl2.  
Thiolates in the assay buffer are known to increase the ATPase activity 
(50).The activities of the mutants were also investigated in the presence of 
thiolates. Along with the other assay ingredients, thiolates were also added. The 
concentration of the thiolate form of cysteine required to generate a constant 
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metal ion: thiolate ion ratio was calculated using the Henderson-Hasselbach 
equation, using a pKa of  8.33 for cysteine and a pH of 7.0.The data obtained 
was fit to the Michaelis-Menten equation, 
v = Vmax x S/ (KM + S) 
where, Vmax equals the maximum velocity, S is the concentration of metal, KM is 
the Michaelis constant for the substrate metal ion(50). 
2.3.7 Measurement of Metal Binding Affinity of the N1-ZntA mutants 
The purified N1-ZntA and N1-ZntA mutants were incubated with 1mM Tris 
(2-carboxy-ethyl) phosphine hydrochloride (TCEP) for 1 h on ice. The buffer 
(10mM Bis-tris, pH 7.0) and metal solutions were deoxygenated and equilibrated 
with argon. The TCEP was removed by passing the protein on a 10 ml Sephadex 
G-25 column under partially anaerobic conditions. For the fluorescence titration, 
the reduced protein was titrated with increasing concentration of different metal 
solutions (Zn2+, Pb2+, and Cd2+). The metal solutions were added to the reduced 
protein using gas tight Hamilton syringe in a sealed cuvette. After each addition 
the solution was mixed well, and the fluorescence spectrum collected. The 
protein was excited at 290nm and an emission spectrum between 300-500nm 
was measured. 
2.3.8 Preparation of Metal bound N1 and N1-mutants 
To measure the stoichiometry of metals bound to N1-ZntA and the site-
specific mutants, the protein was reduced with 1 mM TCEP for 1 h at 4 ˚ C. The 
reduced protein was then incubated with metal salts for 1 h at 4˚ C, the excess 
metal was removed by passing through a Sephadex G–25 column (56).  
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2.3.9 Measurement of Metal Binding Stoichiometry of the N1-ZntA mutants 
by ICP-MS 
The metal content was measured by a PE Sciex Elan 9000 ICP-MS 
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott 
type spray chamber. The RF power was 1000 W, and the argon flow was 
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium 
sensitivity. The data were collected as counts per second. Lead, Cadmium and 
Zinc standards were obtained from VWR. Standard calibration curves were 
determined from samples diluted from stock solutions of 1000 ppm standard 
solutions. The samples and standards solutions were all diluted in 2% HNO3. 
2.3.10 Sensitivity to metal salts 
The sensitivity of E.coli strains LMG194, LMG194 (zntA::cat) and LMG194 
(zntA::cat) transformed with pZntA, or the site specific mutants, to lead, cadmium 
and zinc was measured. The cells were grown in low phosphate media, pH 7.5. 
Cells were grown overnight and then diluted 100 fold in the same media in the 
presence of lead acetate, zinc chloride, and cadmium chloride. Cell growth at 37 
˚C was monitored at 600 nm over a period of 24 hours (56, 69). 
2.3.11 X-Ray Absorption Spectroscopy (XAS)  
XAS was used to study the coordination geometry and ligand environment 
of metal bound to wild type N1-ZntA. This experiment was performed in 
collaboration with Dr. Jim Penner-Hahn’s laboratory at University of Michigan. 
XAS samples of different metals bound to N1-ZntA were prepared as follows. 
The purified proteins were reduced with 1mM TCEP for an hour. The protein was 
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then passed through a 10ml Sephadex G-25 column pre-equilibrated with 10mM 
Bis-Tris to remove the reducing agent, under anaerobic conditions. The reduced 
apo-proteins (~1 mM) were incubated with 0.9 equivalents of metal salt solutions 
for 1 h on ice. The protein was then passed through a 10 ml Sephadex G-25 
column pre-equilibrated with 10 mM Bis-Tris to remove any unbound metal. 
Protein concentrations of the fractions collected were checked by the 
Bichinchonic acid assay. The protein fractions were pooled and concentrated to 
about ~50µl, 30% glycerol was mixed with the protein for uniform glass 
formation. The final protein concentration was determined by BCA and the final 
metal content of the protein was determined by ICP-MS. Then the samples were 
loaded in Lucite cells, with Kapton tape window and immediately frozen in liquid 
nitrogen. XAS data for all the N1-ZntA samples were collected at the Stanford 
Synchroton Radiation Laboratory (SSRL) beamline 9-3. Harmonic rejection was 
achieved by using a pair of Rh-coated mirrors. For Co, Cu, Zn, Cd: K-edge 
fluorescence excitation spectra, and for Pb:L3-edge fluorescence excitation 
spectra, were collected using a Canberra 30-element Germanium solid-state 
detector array equipped with a filter and Soller slits focused on the sample. 
During data collection, the sample temperature was maintained between 10-14 K 
using the Oxford Instruments continuous-flow liquid-helium cryostat. Three 
nitrogen filled ion chambers were used to measure the X-ray intensity at different 
points along the photon path. The first ion-chamber was placed in front of the 
sample to measure the incident intensity (I0), the second ion-chamber was 
placed just after the sample to measure the transmitted intensity (I1) and there 
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was a third ion-chamber (I2) that was placed after I1. The X-ray energies were 
calibrated by collecting the absorption spectra of the reference metal foils 
simultaneously with those of the proteins (e.g. Co foil with the Co-N1 sample). 
The spectra were measured using 5 eV steps in the pre-edge region, 0.3 eV 
steps in the edge and 0.05 Å-1 increments in the extended X-ray absorption fine 
structure (EXAFS) region with integration times ranging from 1 to 25 s in a k3-
weighted manner giving a total scan time of 25 to 40 minutes (total scan time 
was different for different metals) per scan. Six to twelve scans were collected for 
each protein sample depending on the metal concentration and each metal-
bound sample was prepared in duplicates to check reproducibility. Each channel 
for each scan was checked for spectral anomalies and all the channels with 
significant glitches (2−3 channels per scan) were discarded before averaging. In 
order to test for possible radiation damage, the first and the last scan for each 
sample were compared. No change was observed for any metal-bound samples. 
The data were calibrated, reduced and averaged using the EXAFSPAK 
suite of programs (George, G.N. Stanford Synchroton Radiation Laboratoty, 
Menlo Park, CA, 1990.). The first inflection points of different metal foils were 
assigned at certain values for calibration of the data. The averaged data were 
background subtracted and normalized to give the final spectra (70). The data 
were then converted to k-space using the equation k = 20 h/)(2 EEme − where E 
is the incident photon energy and E0 is the threshold (binding) energy of the core 
electron. In our calculation E0 was 7725 eV for Co, 9000 eV for Cu, 9680 eV for 
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Zn, 13055 eV for Pb and 26730 eV for Cd. The EXAFS data can be described by 
the equation: ))(2(sin)2exp()()()( 22
2
kRkk
kR
kSkANk ASASAS
AS
ASSS
s
φσχ +−=∑  
where Ns is the number of scatterers at a distance RAS, As(k) is the effective 
backscattering amplitude, SAS is a scale factor, σ2AS is the Debye-Waller factor 
i.e. the mean-square disorder, φAS(k) is the total phase shift experienced by the 
photoelectron and the sum is taken over all shells of scattering interactions. The 
Fourier transforms were calculated using k3-weighted data over a k range from 
2−12 Å-1
 
to 2−15 Å-1 for different metals. Experimental data were fit with 
theoretical EXAFS amplitude and phase functions calculated using FEFF 7.02. 
Single scattering parameters were calculated for M−O, M−S and M−M using 
appropriate bond lengths taken from the Cambridge Structural Database (CSD) 
for each metal.RAS and σAS were varied, Ns was held fixed at reasonable integer 
values.  
2.4 Results 
2.4.1 The in vivo resistance activity of N1-ZntA mutants to Pb2+, Zn2+ and 
Cd2+ in the growth medium 
The zntA deleted E.coli strain, LMG194 (zntA::cat) is sensitive to toxic 
levels of Pb2+, Zn2+ and Cd2+; it is unable to grow even after 24-30 h and this 
sensitivity can be complemented by wtzntA. The cysteine (C29A, C30A, C31A, 
C35A, C59A and C62A) and the aspartate (D32A, D32N, D58A, D58N) mutants 
were tested for their ability to confer resistance to Pb2+, Zn2+ and Cd2+. For 
comparison, the ∆N-ZntA mutant, in which the N-terminal domain is deleted, was 
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also tested. All the site-specific mutants were able to confer resistance to Pb2+, 
Zn2+ and Cd2+, better than the ∆N-ZntA mutant. In the presence of zinc, a slight 
lag was observed for some mutants compared to ZntA itself. 
 
 
Figure 2.2.  Resistance to Lead, Zinc and Cadmium salts by the wild type strain 
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain 
transformed with the plasmids containing wtzntA, ∆N-ZntA and the site-specific  
mutants in the N-terminal domain. 
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Figure 2.2.  Resistance to Lead, Zinc and Cadmium salts by the wild type strain 
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain 
transformed with the plasmids containing wtzntA, ∆N-ZntA and the site-specific  
mutants in the N-terminal domain. 
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2.4.2 Activity of the Purified N1-ZntA mutants 
The ATPase activity of ∆N-ZntA, ZntA and the site specific mutants at the 
N-terminal domain were measured for the metal ions Pb2+, Zn2+ and Cd2+. 
Previous studies showed that the metals ions stimulate the ATP hydrolysis 
activity of wtZntA, with Pb2+ exhibiting the highest activity (Table2.1) (50). 
Previous studies in the lab have also shown that there is a 4-8 fold increase in 
the ATPase activity of ZntA in the presence of thiolate forms of cysteine or 
glutathione in the assay medium. This is perhaps because the metal thiolate 
complex is a better substrate; within the cell metal ions are expected to be 
present as complexes of small molecule chelators such as cysteine or 
glutathione (50). The activities obtained for wtzntA in the presence of metal ions 
and thiolate form of cysteine in the ratio 1:1 for Pb2+, Zn2+ and Cd2+ were ~2500, 
~ 800 and 1000 nmol/(mg.min), respectively (Tables 2.1,2.2,2.3). All the mutants 
showed higher activities in the presence of the thiolate form of cysteine.  
For the alanine substitutions at Cys29, Cys30, and Cys35, the lead and 
cadmium stimulated activity was similar to that of ZntA (Table 2.1).The mutants 
C31A, D32A, D32N D58A, D58N, C59A, and C62A showed a 2-3 fold decrease 
in activity for Pb2+ (Table 2.1). All the mutants showed higher activities in the 
presence of the thiolate form of cysteine. However, mutations at C31, D32, D58, 
C59 and C62 showed lower activities in comparison to wtZntA, when the lead: 
thiolate complex was provided as the substrate.  
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Table 2.1.  Kinetic Parameters obtained for ZntA, ∆N and the mutants for Pb2+ in 
the absence and presence of the thiolate form of cysteine present at a 
concentration equal to the Pb2+ concentration. 
 
 Pb2+ Pb2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 584 ± 30 5 ± 0.9 2500 ± 70 166 ± 16 
∆N-ZntA 320 ± 6 11.6 ± 0.8 1095 ± 67 55 ± 11 
C29A 574 ± 9.5 2.8 ± 0.2 2194 ± 34 89 ± 4.3 
C30A 557 ± 15 5.7 ± 0.85 2066 ± 51 66 ± 5.6 
C31A 264 ± 8 10 ± 1 1756 ± 56 115 ± 10 
D32A 284 ± 8 8.4 ± 0.8 1422 ± 28 37 ± 3 
D32N 317 ± 22 6.7 ± 2.3 817 ± 30 70 ± 8 
C35A 611 ± 30 14 ± 2 2361 ± 54 249 ± 13 
D58A 201 ± 3.4 3 ± 0.27 954 ± 26 26 ± 3.2 
D58N 325 ± 20 11 ± 2 1145 ± 69 268 ± 37 
C59A 263 ± 5 7.7 ± 0.53 1198 ± 27 236 ± 12 
C62A 132 ± 3.8 3.2 ± 0.46 1045 ± 16 47 ± 2.7 
 
All the alanine substitutions and the asparagine substitutions at the 
conserved cysteine and aspartate residues displayed 2-3 fold lower activities in 
the presence of Zn2+ (Table2.2). Zinc:thiolate induced activities of the mutants is 
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higher. However, substitutions at C31, D32, D58, C59 and C62 showed lower 
activities in comparison to wtZntA, when zinc: thiolate complex was provided as 
the substrate. 
Table 2.2  Kinetic Parameters obtained for ZntA, ∆N and the mutants for Zn2+ in 
the absence and presence of the thiolate form of cysteine present at a 
concentration equal to the Zn2+ concentration. 
 
 Zn2+ Zn2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 250 ± 13 10 ± 2 710 ± 28 96 ± 11 
∆N-ZntA 81 ± 7 9.3 ± 1.2 372 ± 6 42 ± 3 
C29A 86 ± 5.5 7 ± 1.6 1096 ± 28  36 ± 3.8 
C30A 92 ± 3.25 3 ± 0.87 1005 ± 30 148 ± 13.4 
C31A 61 ± 1.48 2.24 ± 0.31 786 ± 16.2 105 ± 6.5 
D32A 85 ± 3 3.2 ± 0.6 748 ± 10 71 ± 3.1 
D32N 127 ± 13 15 ± 4.8 753 ± 11.8 94 ± 9.7 
C35A 75 ± 1.8 4.7 ± 0.47 697 ± 19 154 ± 11 
D58A 82 ± 3 3.8 ± 0.65 587 ± 7.4 75 ± 3 
D58N 100 ± 9.7 16 ± 4 730 ± 19 74 ± 5.4 
C59A 60 ± 2 3.22 ± 0.5 568 ± 21 127 ± 13.7 
C62A 51 ± 1 4.7 ± 0.4 526 ± 15 70 ± 7.2 
 
69 
The cadmium stimulated activity for the alanine substitutions at Cys29, 
Cys30, and Cys35, was similar to that of ZntA (Table2.3). C31A, D32A, C59A 
and C62A showed slightly lower activities in the presence of Cd2+. 
Table 2.3.  Kinetic Parameters obtained for ZntA, ∆N and the mutants for Cd2+ in 
the absence and presence of the thiolate form of cysteine present at a 
concentration equal to the Cd2+ concentration. 
 
 Cd2+ Cd2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 250 ± 13 10 ± 2 710 ± 28 96 ± 11 
∆N-ZntA 81 ± 7 9.3 ± 1.2 372 ± 6 42 ± 3 
C29A 59 ± 1.3 2.2 ± 0.28 1103 ± 19.7  118 ± 6.11 
C30A 84 ± 3 4.6 ± 1.2 1309 ± 95 226 ± 39 
C31A 15 ± 1.8 7.3 ± 2.5 818 ± 16 23 ± 2.1 
D32A 22 ± 2.4 3 ± 1.3 744 ± 13 69 ± 4.2 
D32N 56 ± 4 0.3 ± 1.3 566 ± 13 14 ± 1.7 
C35A 97 ± 6.66 6.9 ± 1.4 1041 ± 31 250 ± 17 
D58A 76 ± 2 3.3 ± 0.35 703 ± 17 27 ± 3 
D58N 57 ± 4 2.5 ± 0.8 552 ± 48 42 ± 14 
C59A 52 ± 3 2.27 ± 0.6 635 ± 6.4 129 ± 3.7 
C62A 26 ± 3.7 6 ± 1.12 872 ± 16 28 ± 2.2 
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2.4.3 Stoichiometry of Metal Binding to N1-ZntA mutants using ICP-MS 
To understand the importance of the cysteine and aspartate residues in 
the CCCDXXC and the DCXXC in binding metal ions, we determined the metal 
binding stoichiometries of the mutants in the isolated fragment N1-ZntA, purified 
with a strep – tag (Table 2.4). Wild-type N1-ZntA can bind to one metal ion with 
high affinity (56). Binding stoichiometry for C29A, C30A, and C35A was 1 for 
Pb2+ and Cd2+. The results indicate that the alanine and asparagine substitutions 
at C31, D32, D58, C59, and C62, disrupted the binding of Pb2+ and Cd2+ while 
residues C29, C30 and C35 appear not to be important in binding these two 
metal ions. Surprisingly, it was observed that any mutations in the upstream 
CCCDXXC and downstream DCXXC motifs affected zinc binding completely, 
though earlier studies showed that Zn2+ binding was unaffected when the 
upstream motif was deleted in a ∆46-ZntA mutant, which lacks the first 45 
residues (5, 56). 
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Table 2.4. Stoichiometry of Metal bound to N1-ZntA and N1-ZntA mutants using 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS); x = No Binding. 
 
 Lead Zinc Cadmium 
N1-ZntA 1 ± 0.0 1 ± 0.1 1 ± 0.0 
C29A-N1ZntA 1 ± 0.0 x 1 ± 0.0 
C30A-N1ZntA 1 ± 0.0 x 1.1 ± 0.0 
C31A-N1ZntA x x x 
D32A-N1ZntA x x x 
D32N-N1ZntA x x x 
C35A-N1ZntA 1 ± 0.0 x 0.8 ± 0.0 
D58A-N1ZntA x x x 
D58N-N1ZntA x x x 
C59A-N1ZntA x x x 
C62A-N1ZntA x x x 
 
2.4.4  Affinity of Pb2+, Zn2+ and Cd2+ for the amino terminal metal binding 
site mutants using direct fluorescence quenching 
The N–terminal domain has one tryptophan residue. The fluorescence 
emission of the tryptophan residue is quenched when this isolated domain binds 
metal ions. This tryptophan fluorescence quenching is a useful method to 
measure the affinity of different divalent metal ions. A titration of N1-ZntA with 
increasing concentrations of Pb2+ is shown in Figure 2.3; similar decreases in 
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fluorescence were observed for Cd2+ and Zn2+ also. The change in fluorescence 
intensity at 340 nm was plotted vs. the metal ion concentration in Figure 2.4. The 
data were fit to the following equation (using Kaleidagraph) that assumes a 1:1 
binding model for the protein.  
N1-ZntA + M2+ ↔ N1-ZntA·M2+ 
KE = [E·M2+]/ [E ][M2+ ]    Equation(2) 
where KE is the association constant of the metal and protein, [E], [M2+] and 
[E·M2+] are the concentrations of initial enzyme, initial metal and metal complex 
with enzyme. The association constants calculated from the titration data are 
summarized in Table 2.5. The affinity of the buffer, Bis-Tris was taken into 
account when fitting the data. Mutants C31A, D32A, D32N, D58A, D58N, C59A, 
and C62A did not show any fluorescence quenching, suggesting they were 
unable to bind lead, in agreement with the results from ICP-MS. 
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Figure 2.3. Representative spectra obtained during titration of 10 µM N1-ZntA 
with increasing concentrations of Pb2+ (0-15 µM) in 10 mM Bis-Tris, pH 7.0 at 
20˚C. The arrow denotes the decrease in fluorescence as increasing amounts of 
Pb2+ are added. 
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Figure 2.4. Plot of change in fluorescence emission at 340 nm from Figure 2.5 
above as a function of the added lead salt concentration. The data were fitted to 
equation 2. 
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Table 2.5. Association constants for the binding of lead, zinc and cadmium to the 
N1-ZntA mutants. 
 
 Lead 
M-1 
Zinc 
M-1 
Cadmium 
M-1 
N1-ZntA (1.8 ± 0.8) x 109 (4.9 ± 2) x 107 (3.6 ± 0.9) x 107 
C29A (8.1 ± 4.5) x 109 x (5.24 ± 2) x 107 
C30A (4.6 ± 2.5) x 109 x (1.13 ± 0.5) x 107 
C35A (2.35 ± 0.9) x 109 x (6.2 ± 2.2) x 107 
 
2.4.5 Analysis of Lead, Zinc, Cadmium, Cobalt and Copper binding by X-ray 
absorption spectroscopy 
Although structural information of a portion of N1-ZntA bound to zinc has been 
solved, details regarding the co-ordination environment of lead and cadmium 
bound to N1-ZntA are not available. Here, XAS has been used to study the 
structure of lead, zinc, cadmium ions bound to N1-ZntA, thus providing detailed 
information with respect to ligand environment and geometry. The co-ordination 
environment of cobalt and copper bound to N1-ZntA was also examined, 
because our metal stoichiometry experiments suggested that cobalt binding to 
N1-ZntA is sub stoichiometric unlike the other metal ions, and in the case of 
copper, to test whether N1-ZntA can bind to Cu2+, since it has the CXXC motif, 
observed in Cu+-transporting pumps. 
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Energy 
 
N1-ZntA-Lead  
The N1-ZntA-Pb complex is best simulated with 3 sulfur ligands at a 
distance of 2.66 Å. Normalized L3-edge spectra of N1-ZntA-Pb sample is 
presented in Figure 2.5a .The EXAFS data were extracted using the value of E0 
= 13055 eV. The EXAFS data and the Fourier Transform of the EXAFS (k range 
of 1-14 Å-1) are plotted in Figure 2.5b. The data are in blue and fits are in red 
dotted lines. The best fit results are presented in Table 2.6. No significant 
second shell interaction was found for any of them. 
0
20
40
60
80
100
1.298 104 1.3 104 1.302 104 1.304 104 1.306 104 1.308 104 1.31 104 1.312 104
 
 
Figure 2.5a. Normalized edge spectra of Pb L3-edge for the N1-ZntA-Pb 
sample. 
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Figure 2.5b. EXAFS data and fit for the N1-ZntA-Pb sample. 
 
Figure 2.5c. Graphical representation of approximate lead coordination 
geometry. 
N1-ZntA-Zinc 
The N1-ZntA-Zn sample was best modeled to two oxygen and two sulfur 
atoms. The normalized K-edge spectra of Zinc are presented in Figure 2.6a.  
The EXAFS data were extracted using the value of E0 = 13055 eV. The EXAFS 
data and the Fourier Transform of the EXAFS (k range of 1-14 Å-1) are plotted in 
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Figures 2.6b. The data are in blue and fits are in red dotted lines. The best fit 
results are presented in Table 2.6.  
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Figure 2.6a. Normalized K-edge spectra of N1-ZntA-Zn sample. 
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Figure 2.6b. EXAFS data and fit for N1-ZntA-Zn sample. 
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Figure 2.6c. Graphical representation of approximate zinc coordination 
geometry. 
N1-ZntA-Copper 
Cu k-edge spectrum of the N1-ZntA-Cu sample is normalized and 
presented in Figure 2.7a. From the energy of the edge jump it is evident that the 
oxidation state of the metal is Cu+, though the sample was prepared by 
incubating the reduced N1-ZntA with Cu2+ in the absence of any reductant. The 
XANES feature at the energy of 8983.5 eV is consistent with the 1s→4p 
transition of the Cu+ center and also similar with those of the trigonal Cu+ model 
complexes (71). The EXAFS data were extracted using the value of E0 = 9000 
eV. The EXAFS data and the Fourier Transform of the EXAFS (k range of 1-12.7 
Å are plotted in Figs 2.7b and 2.7c. The data are in blue and fits are in red dotted 
lines. The best fit results are presented in Table 2.6. The first shell interaction for 
Cu+ can be best modeled by 3S ligands at a distance of 2.26 Å. This Cu-S 
distance is in agreement with the trigonal geometry and is longer than the linear 
Cu-S distance (~2.17 Å). The second shell interaction can only be modeled by a 
Cu-Cu interaction pointing towards the formation of a binuclear Cu complex in 
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solution, which is in agreement with the XAS studies of ATP7B Wilson disease 
protein (72). 
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Figure 2.7a. Normalized K-edge spectra of N1-ZntA-Cu sample. 
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Figure 2.7b. EXAFS data and fit for N1-ZntA-Cu sample. 
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N1-ZntA-Cobalt 
From the edge spectra (Figure 2.8a) we can conclude that the Co is in the 
+2 oxidation state with a weak pre-edge peak at around 7709 eV. The EXAFS 
data were extracted with E0 = 7725 eV. The k3 weighted EXAFS data and Fourier 
Transform (k =1-15 Å-1) are presented in Figures 2.8b. The data is plotted in blue 
and the fit is in red dotted line. The best fit parameters are presented in table 
2.6. From the fitting results Co2+ appears to be in a distorted tetrahedral 
geometry. The first shell peaks can be best modeled with a mixture of both O/N 
and S interactions with 1 O/N and 3S around the Co2+ center. Our previous 
results have shown that binding of Co2+ to N1-ZntA was sub stoichiometric, 
suggesting that one Co2+ bridges two protein molecules. 
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Figure 2.8a. Normalized Co (II) k-edge absorption spectrum in N1-ZntA-Co 
sample. 
 
Energy 
82 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
0 1 2 3 4 5 6
N1-ZntA Cobalt
Fit
FT
 
M
a
gn
itu
de
R + α  (Å)
   
Figure 2.8b. EXAFS and Fit for the N1-ZntA-Co sample. 
N1-ZntA-Cadmium 
Cd k-edge spectrum of the Cd-Znta sample is normalized and presented 
in Figure 2.9a. The EXAFS data were extracted using the value of E0 = 26730 
eV. The EXAFS data and the Fourier Transform of the EXAFS (k range of 1-15 
Å-1) are plotted in Figures 2.9b & 2.9c. The data are in blue and fits are in red 
dotted lines. The best fit results are presented in Table 2.6. From the best fit 
results it is difficult to predict whether the Cd is present in a 5 or 6 coordinate 
environment. The first shell interaction for Cd can be best modeled by either 
3O/N and 2S or 3O/N and 3S ligands. The low z ligands O/N are present at a 
distance of 2.35 Å and the S ligands are present at a distance of 2.57 Å. Though 
the goodness of fit value is better for the 5-cocordinate fit, the Debye-Waller 
factors for both O/N and S are very low. The second shell interaction can be 
modeled by a Cd-Cd interaction pointing towards the formation of a binuclear Cd 
complex in solution. 
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Figure 2.9a. Normalized Cd (II) k-edge absorption spectrum in N1-ZntA-Cd 
sample. 
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Figure 2.9b. EXAFS and 5 co-ordinate fit for the N1-ZntA-Cd sample. 
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Figure 2.9c. EXAFS and 6 co-ordinate fit for the N1-ZntA-Cd sample. 
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Table 2.6. EXAFS Fitting results for Lead, Zinc, Cadmium, Copper and Cobalt. 
 
Sample 
 
Liganda 
 
CNb 
 
R (Å)c 
σ
2
 x103 
(Å2)d 
 
∆E0 
 
F x10-3 e 
Lead S 3 2.66 2.81 -16.6 0.2083 
Zinc 
 
O 2 2.0 3.90 -13.4 0.3545 
S 2 2.31 1.73 
 
 
Cadmium 
S 2 2.58 1.00  
-4.83 
 
0.8174 Cd 1 3.29 8.36 
O 3 2.35 1.08 
S 3 2.57 3.23  
-6.42 
 
 0.8453 Cd 1 3.28 3.28 
O 3 2.35 2.35 
 
Copper 
S 3 2.26 5.04  
-14.4 
 
0.1598 Cu 1 2.70 9.53 
 
Cobalt 
S 3 2.26 3.38  
-12.006 
 
0.8785 Co 1 1.90 2.09 
 
a = Scattering atoms, b = Average metal-ligand coordination number,  
c = Average metal – ligand bond length, d = Average Debye Waller factor, 
e = number for degrees of freedom weighted mean square deviation between 
data and fit 
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2.5 Discussion 
The amino terminal domain of PIB type ATPases has been studied, but 
very little is known about the molecular basis of metal selectivity and specificity 
of this family of proteins. Sequence analysis has shown that the CXXC motif is 
present in copper and lead/zinc/cadmium transporting ATPases; it is also 
present in some other proteins including copper chaperones and mercury 
binding proteins. Studies of the Cu+ ATPases, which can have multiple copies of 
CXXC motif, and CadA, a Cd2+-ATPase, have demonstrated that the cysteines in 
this motif are metal binding ligand sites (8). ZntA not only has the CXXC motif 
but also a CCCDCXXC motif in its amino terminal domain. ICP-MS 
measurements have shown that N1-ZntA binds to a wide variety of metal ions 
with a stoichiometry of one, with the exception of cobalt. The N-terminal domain 
of the Cu+ ATPase also binds to different metal ions: Cu+, which is a substrate, 
and to zinc and cadmium which are not substrates, through different geometry 
(10, 61). Some PIB ATPases like the Cu2+ ATPases have a histidine rich amino 
terminal domain which may be specialized for binding to divalent copper, some 
others like the cobalt transporters do not have the amino terminal domain (47). 
Thus it is observed that PIB ATPases have different conserved metal binding 
motifs in the N-terminal domains that maybe involved in conferring metal 
selectivity. Previous results in the lab have suggested that the extra cysteines 
located upstream of the CXXC motif play a role in lead binding (56). To 
investigate further the residues involved in conferring selectivity in ZntA, we 
constructed individual alanine mutants and additionally the Asp32 and Asp58 
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were mutated to asparagines. The residues were replaced by alanine to avoid 
any possibility of side chains acting as metal ligand. In D32N and D58N, the 
carboxylate oxygens of aspartate side chain were replaced by the amide of 
asparagine to examine if a charged residue at this position is essential for the 
activity and the metal binding. In vivo, all the mutants display similar resistance 
profile as wtzntA for lead and cadmium, but Cys31, Cys59, Cys62, Asp32, 
Asp58, Asn32 and Asn58 all show a slight lag in the presence of zinc 
(Figure2.2). The individual alanine substitutions at Cys31, Cys59, Cys62, Asp32, 
Asp58 and the asparagine substitutions at Asp32 and Asp58 showed 2 fold 
lower ATPase activity with lead and 2-3 fold lower activity for zinc and cadmium 
when compared to wtzntA (Tables 2.1,2.2,2.3). In vivo, metals are bound to 
different chelators such as citrates, histidines or thiolates. When the metal is 
provided as a metal thiolate complex in the assay medium, a 4-8 fold increase in 
the ATPase activities of ZntA for lead, zinc and cadmium is observed. When 
metal thiolate complex was provided as the substrate, the thiolates increased the 
ATPase activity of the mutants with lead, cadmium and zinc. The lead: thiolate 
complex induced activity of Cys31, Cys59, Cys62, Asp32, Asp58, Asn32, and 
Asn58 showed a 5-6 fold increase, and the cadmium, zinc thiolate activities for 
the mutants were similar to that of wtzntA (Table 2.1, 2.2, 2.3). This may be 
because the thiolates may compensate for the replaced cysteine and aspartate, 
thus increasing the activities of the mutants.  
Previous metal binding studies, both by ICP-MS and by metal titration, 
show that N1-ZntA has a single high affinity metal binding site; it binds to a single 
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lead, zinc and cadmium ion. The mutants in N1-ZntA: - C29A, C30A, C35A are 
able to bind to lead and cadmium with a stoichiometry of 1 with high affinity, this 
was expected since they showed in vitro activities comparable to wtzntA (Table 
2.4). Values of lead and cadmium binding affinity obtained for C29A, C30A and 
C35A were similar to those obtained for N1-ZntA (Table 2.5).Thus, C29, C30 
and C35 are not involved in binding lead or cadmium. However the mutants at 
C31, D32, D58, C59 and C62 were unable to bind lead and cadmium, 
suggesting that these residues played a role in binding these two metal ions. 
Surprisingly none of the N1-ZntA mutants were able to bind zinc. Zinc has a very 
small ionic radius (0.88Å), and it is much smaller than lead and cadmium (4). 
Structural studies of a portion of the N-terminal domain of ZntA (residues 46-
118) has been solved; from this it was observed that zinc binds with a tetrahedral 
coordination to the two cysteine and the aspartate residue of the GMDCXXC 
motif and has no contribution from the upstream motif (5). Our results suggest 
that the upstream cysteines together with the Asp32 form a structure that 
precludes any kind of interaction of the upstream site with the downstream zinc 
binding site, leaving the DCXXC site free to bind zinc. To probe the local 
structural environment of zinc, lead and cadmium metal bound to N1-ZntA metal 
binding site, X-ray absorption spectroscopy was used. The binding of lead, 
cadmium and zinc at the amino terminal site is different for each of these metal 
ions. Lead binds with a trigonal geometry to the two cysteines of the CXXC and 
Cys31 of the upstream motif, this coordination environment is similar to Pb2+ 
binding in some proteins in thiol rich environments (Figure2.5, Table 2.6) (63). 
89 
Similar to the solution structure of the Zn2+ bound form of N2-ZntA, zinc bound to 
N1-ZntA with 4 co-ordinate geometry to two sulfurs (Cys59 and Cys62) and two 
oxygens; one of the oxygens is from the Asp58 and the other may be from water 
or the upstream Asp32 (Figure 2.6, Table 2.6)(7). 
 In CadA, a Cd2+ ATPase from Listeria monocytogenes, Cd2+ is bound 
with a tetrahedral geometry at the N-terminus by two Cys and two oxygen atoms 
of a conserved acidic residue located at a distance (60). Sequence alignments of 
the N-termini of CadA, ZntA and CopA like proteins have shown that all these 
proteins have a conserved CXXC motif. CadA like sequences have a conserved 
acidic residue Glu61 located in loop 5 which is spatially positioned near the 
CXXC motif, but in the case of ZntA homologues there is a conserved Asp in 
loop1; solution structure has demonstrated that it is involved in zinc binding. 
However, in Cu (I)-ATPases this acidic residue is absent. This indicates that the 
presence of the acidic residue provides an appropriate coordination sphere for 
divalent metal ions such as zinc and cadmium. In N1-ZntA, since the carboxylate 
ligand is located adjacent to the metal cysteine ligands, the metal binding site is 
better fit for zinc which is a smaller ion than cadmium. 
Unlike CadA, EXAFS data suggest that cadmium bound to N1-ZntA 
displays 5 or 6 coordinate geometry. Structural studies on CadA have also 
shown that it forms a homodimer containing one cadmium atom per monomer. In 
the case of N1-ZntA also, Cd-Cd interaction was observed. It is possible that the 
two cadmium atoms share two thiolate ligands; additionally they may bind to 
another S atom and 3 oxygen atoms (Figure 2.9, Table 2.6).  
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 α1                                                                            α2 
                 β1                                                        β2                β3                                                    β4 
CadA  EKTVYRVDGLSCTNCAANFCRNVKEIEGVTEAIVNFGASKITVTGEASIQQVEQAGAFEHLKII 
                                              α1    
                 β1                                                         β2               β3                           α2               β4 
ZntA  TRYSWKVSGMDCAACARKENAVRQLAGVNQVQVLFATEKLVVDADN-DIRAQVESAVQKAGYSLR 
                     α1 
        β1           β2        β3    α2 β4 
CopA  KEIAMQVSGMTCAACAARIEKGLKRMPGVTDANVNLATETSNVIYDPAETGTAAIQEKIEKLGYH 
 
Figure 2.10 Sequence alignments of the N-terminal domain of PIB ATPases. 
N1-ZntA binds to cobalt and copper in addition to lead, cadmium and zinc. 
The cobalt and copper structural environment was also examined. Co2+ binds to 
3 sulfurs and a oxygen (Figure 2.8), our metal stoichiometry results have shown 
that binding of Co2+ to N1-ZntA is sub stoichiometric, suggesting that one Co2+ 
bridges two protein molecules such that it cannot be displaced by other metal 
ions (56). Co2+ ATPases lack the N-terminal domain; this may be because the 
CXXC motif is not ideal for Co2+ binding and subsequent transfer to the transport 
site in the membrane. 
Studies on the Wilson’s disease protein (ATP7B) have shown that not 
only is the bound copper in the +1 oxidation state, but also Cu2+ atoms get 
reduced to Cu+ upon binding to the domain. Simulations of the copper EXAFS of 
for N1-ZntA, with three sulfurs and one copper are best fit with a ligand 
environment of 3.0 Cu-S atoms at 2.26 and one Cu-O at 1.98 Å (Figure 
2.7,Table2.6), suggesting that Cu+ displays a tetrahedral geometry. The 
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cysteine-rich motif in N1-ZntA is not ideal for binding Cu2+, since it is reduced to 
Cu+. This may explain why Cu2+-ATPases have a histidine rich motif. 
Over the past several years studies of many metalloproteins have all 
pointed towards the fact that metal selectivity is not a result of thermodynamic 
parameters like binding affinity. Selectivity is achieved through specific co-
ordination geometry which leads to the correct changes in protein conformation. 
ZntA is a transporter that has to detoxify E.coli against three different divalent 
metal ions of very different sizes. The DCXXC motif is a specialized zinc binding 
motif. In order to accommodate the much larger Pb2+ ion, an additional cysteine 
from the upstream motif has been conserved. Thus the N-terminal domain of 
ZntA has been evolved to bind both lead and zinc efficiently. Unfortunately, 
cadmium, which has similar coordination preferences as zinc, but falls in the 
middle of the other two in ionic radii, is not bound optimally by N1-ZntA. This 
results in Cd2+ being the least efficient substrate for ZntA. The transporter 
compensates for the lower activity with Cd2+ by producing more of the protein 
when its regulator, ZntR is induced by Cd2+ (26). In conclusion, this study on N1-
ZntA has shown that Cys31 from the CCCDXXC motif, as well as the GMDCXXC 
conserved motif play important roles in metal selectivity to two metal ions of 
highly different sizes.  
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CHAPTER 3 
THE N-TERMINAL DOMAIN OF ZNTA: IT’S ROLE AS AN ATTACHED METAL 
CHAPERONE TO THE TRANSPORTER 
Evidence is presented in this chapter that the role of the N-terminal domain of 
ZntA is to act as a metal chaperone to the core transporter domain. 
3.1 Introduction 
 Inside the cell, several regulatory proteins are in place to control the 
intracellular concentration of essential metal ions and as well as toxic metal ions. 
An example is metallothionein, which is a metal sequestering protein. It binds to 
copper and zinc, serving as a reservoir for these metal ions, and additionally it 
also binds to cadmium and helps in the detoxification of this ion (1). In addition to 
the metal sequestering proteins, we also have metallochaperones, which bind to 
metal ions and transfer them to target proteins. Copper chaperones (Atx1, CopZ, 
CCS) (2) are the best studied ones; some other examples of chaperone proteins 
are UreE which is a nickel chaperone that delivers Ni2+ to urease (14), frataxin 
and human poly(rc) binding protein 1(PCBP1) are iron chaperones that deliver 
iron to iron sulfur clusters and ferritin (4). But, so far no   metallochaperone 
proteins are known for zinc. Therefore, how do zinc ions exist in organisms? It is 
likely that zinc ions are chelated to small molecule chaperones – such as 
cysteines, glutathione, citrate, inside the cell, as well as stored in organelles or 
bound to storage proteins such as metallothionein. 
Zinc is an essential transition metal required for many biological reactions, 
but at the same time any increase or decrease in the cellular zinc concentration 
can have adverse effects. ZntA is a member of the PIB2 ATPase family which is 
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one of the components involved in zinc homeostasis in E.coli (5). ZntA consists 
of 8 transmembrane helices and a hydrophilic metal-binding N-terminal region.  
For all P-type ATPases, binding of metal ions at the transmembrane 
region is a crucial step in the reaction mechanism. How does the transmembrane 
region get the metal ion? In the case of Cu+-ATPases, the metal ion is acquired 
directly from the cytoplasmic pool by several copper chaperones   that deliver the 
metal specifically to the Cu+ transporters (6). This metal delivery has been 
extensively studied in Cu+-ATPases. 
ZntA has two metal binding sites, one in the N-terminal domain and the 
other in the membrane domain (7). The N-terminal domain is about ~110 
residues long and it has a characteristic CXXC metal binding sequence which is 
conserved in many PIB ATPases (CopA, CopB, CadA), Cu+ chaperones like 
Atox1, Atx1 and CopZ, metallothioneins, and MerA which is a mercury binding 
protein (8, 66). Studies in some of the bacterial Cu+ transporters have shown that 
the N-terminal metal binding domain binds to Cu+ with high affinity; the deletion 
of this domain does not prevent the activation of the copper transporter but it 
does reduce the activity of the transporter (10, 11). Recently it was shown that 
Archaeoglobus fulgidus Cu+ chaperone CopZ interacted and delivered Cu+ to 
CopA (64). Another enzyme, mercuric ion reductase (MerA), which is involved in 
Hg2+ acquisition and reduction in the cytoplasm of bacterial cells, also has the 
characteristic CXXC sequence (66). Early studies indicated that the presence of 
NmerA is dispensable to the cells; however it was later prove that the N-terminal 
domain of NmerA binds to Hg2+ ion and delivers it to the catalytic domain of 
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MerA at kinetically efficient rates (66). Studies in our lab have shown that a 
mutant lacking the N-terminal domain had 2-3 fold lower activity than the full 
length protein, suggesting that the presence of the N-terminus increases the 
catalytic activity.  
 
 
Figure 3.1. The two metal binding sites in ZntA, one in N-terminal fragment(A) 
and the second site in the membrane domain(B). 
Both the metal binding domains bind to lead, zinc and cadmium with a 
stoichiometry of 1; the binding affinity for the above mentioned metal ions at the 
two sites are similar (Pb2+ ~ 109M-1, Zn2+ and Cd2+ ~108M-1) (56, 63). These 
results point toward the fact that metal ion exchange between the two sites is 
feasible. Since no protein chaperones have been identified for zinc in E.coli, we 
wondered if the N-terminal domain acts to acquire zinc ions efficiently from small 
molecule chelators in the cytosol and then deliver it to the transmembrane metal-
binding site. In the present work, our goal was to investigate the function of the 
A 
B 
98 
N-terminal domain of ZntA (N1-ZntA) as an attached metal chaperone to the 
transporter. Our theory is that the N-terminal metal binding domain being solvent 
exposed, binds to metal ions more efficiently than the membrane site and then 
directly delivers the metal to the transmembrane site. To examine this theory, the 
activity of ∆N and ZntA using metal bound N1-ZntA as the substrate was 
measured. In the presence of metal bound N1-ZntA everted membrane vesicles 
of ∆N-ZntA and ZntA displayed ATP dependent lead, zinc, cadmium 
accumulation. Double cysteine mutants in a truncated construct of ZntA (∆46-
ZntA) labeled with pyrene maleimide displayed excimer formation, indicating that 
the two metal binding regions are located in close proximity. The interaction 
between N1-ZntA and ∆N was shown by a fluorescence resonance energy 
transfer (FRET) experiment where the energy transfer between pyrene 
maleimide labeled ∆N-ZntA and coumarin maleimide labeled N1-ZntA was 
observed. These studies demonstrate that that the metal-binding site in N1-ZntA 
is spatially close to the metal-binding site in the transmembrane region, and it is 
feasible for the two sites to exchange metal ions. Thus, we believe that N1-ZntA 
performs the role of an attached metal chaperone that binds to metal ions from 
small molecule chelators in the cytosol and comes in close proximity of the 
membrane domain to facilitate direct metal delivery to the transmembrane site. 
3.2 Materials 
Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained from 
Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the 
ATPase activity assay and standard metal solutions were purchased from 
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Sigma. The fluorophores pyrene maleimide, dibromobimane, and coumarine 
maleimide were purchased from Molecular Probes. Metal standards used for 
inductively coupled plasma mass spectrometry (ICP-MS) were from VWR. 
3.3 Methods 
3.3.1 Construction of ZntA and ∆N-ZntA with a carboxyl – terminal strep tag  
ZntA and ∆N-ZntA were cloned into the expression vector pBAD/Myc-
HisC by polymerase chain reaction (PCR). A Nco1 site was generated at the 
initiation codon, and an EcoR1 site was created downstream of the termination 
site using the following oligonucleotides, 5’- ATA AGA TTA GCG GAT CCT-3’ 
and 5’- GCG GAA TTC TTA TTT TTC GAA CTG CGG GTG GCT CCA TCT 
CCT GCG CAA C-3’. The PCR product and the vector were digested with Nco1 
and EcoR1, after which the amplified DNA fragment and the vector were ligated 
together to generate ZntA. The gene for ∆N-ZntA was created with residues 2-
106 being deleted by PCR, using the oligonucleotide, 5’- CGT GCC ATG GCA 
GGC TAT TCC CTG CGC -3’ and the same reverse primer used for making the 
ZntA-strep. The resulting PCR product and the vector, following digestion with 
Nco1 and EcoR1, were ligated together to create p∆N-ZntA. The sequence of 
both ZntA and ∆N-ZntA was confirmed using DNA sequencing analysis; both the 
genes were in frame with the strep tag at the carboxyl terminus. 
3.3.2 Construction N1-ZntA with carboxyl - terminal strep tag 
N1-ZntA(1-111 amino acids) was created by PCR using the plasmid 
pZntA as template and the oligonucleotides 5’-CTA CTG TTT CTC CAT ACC C 
3’ as forward primer and 5’ GCG CTC GAG TTA TTT TTC GAA CTG CGG GTG 
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GCT CCA CAG GGA ATA GCC TGC 3’ as the reverse primer. The amplified 
PCR product was cloned into pET16b using Nco1 and Xho1 sites; this was then 
transformed into E.coli strains TG1 and Bl21.  
3.3.3 Construction of Co-expression vector containing both ∆N–ZntA 
(membrane domain) and N1–ZntA (N-terminal domain) in pBADmycHisP  
N1-ZntA and ∆N-ZntA were cloned into pBADmycP (commercially 
available pBADmycHisC modified with a built in Precision Protease cleavage site 
to enable the His tag to be cleaved off) by polymerase chain reaction. The 
forward and reverse primers used for ∆N-ZntA were 5’- GCG TGC CAT GGC 
AGG CTA TTC 3’ and 5’ GAT CTC GAG TCA TCT CCT GCG CAA CAA 3’ 
respectively. Then following digestion with Nco1 and Xho1 the PCR product and 
pBADmycP were ligated and cloned into E.coli strain TG1. N1–ZntA polymerase 
chain reaction was set up using 5’ TAA GAA TTC AGG AGG AAT TAA CCA 
TGG CG 3’ as the forward primer and 5’ CCG AAG CTT TCA TTT TTG CAG 
CGC AGA 3’ as the reverse primer. The PCR product and pBADmycP were 
subjected to double digestion with EcoR1 and HindIII; the fragments were then 
ligated and transformed to E.coli strain TG1. Both pBAD-N and pBAD-∆N were 
digested with EcoR1 and HindIII, the small fragment from pBAD-N was ligated to 
the large fragment of pBAD-∆N digest and then cloned into E.coli strains TG1 
and deletion LMG194 (zntA::cat). The sequence was confirmed by DNA 
sequencing analysis; both N1-ZntA and ∆N-ZntA were in frame. 
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Figure 3.2. Scheme for construction of Co-expression vector. 
3.3.4 Construction of double and single cysteine mutants in ∆46-ZntA 
∆46-ZntA was chosen instead of ZntA since this fragment of ZntA 
contained cysteine residues from the two metal binding sites and the upstream 
cysteine 4 residues in the first 45-residue fragment were absent. Thus, ∆46-ZntA 
only has five remaining cysteines in total, C59 and C62 from the N-terminal 
CXXC motif, C392 and C394 from the transmembrane metal binding site, and 
the non-conserved C518.  The main purpose of creating these mutations was to 
generate proteins with two Cys residues, one in each of the 2 metal binding 
sites. C59A/ZntA, C62A/ZntA, C392A/C518A/ZntA and C394A/C518A/ZntA 
plasmids were transformed into DAM methylaseƟ strains. Bcl1 digestion of DNA 
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is inhibited by the dam gene product of E.coli, which methylates the 6N position 
of adenine within the sequence GATC. Therefore Bcl1 digestion of DNA isolated 
from E.coli dam cells is inhibited in methylated TG*ATCA and DAM methylaseƔ 
strain was used. The plasmids were digested with Bcl1 and EcoR1, the small 
fragment from C59A/ZntA and C62A/ZntA were ligated with the large fragment 
from C392A/C518/ZntA and C394A/C518A and transformed into E.coli strain 
TG1. The sequences were verified by DNA sequencing to check for presence of 
triple mutations in ZntA. The plasmids containing the triple mutants were 
amplified by PCR using forward primer 5’ TCT GAA CAT ATG TCC GGC ACC 
CGC 3’ and reverse primer 5’ GAC GGC GCT ATT CAG ATC CTC 3’, this lead 
to the deletion of first 46 residues of ZntA.  Following digestion, the PCR product 
and pBADmycHisC were ligated and cloned into E.coli strain TG1 and deletion 
LMG194 (zntA::cat). The ∆46-ZntA single mutants were created using Quick 
change site directed mutagenesis kit from Stratagene. For ∆46-
C59A/C392A/C394A/C518A/ZntA the forward and reverse primers used were 5’ 
CTG ATT GGC GCC CCG GCT GCG TTA GTG ATA TCA ACG CCT G 3’ and 
5’-CAG GCG TTG ATA TCA CTA ACG CAG CCG GGG CGC CAA TCA G 3’ 
respectively. The ∆46-C59A/C62A/C392A/C394C/C518A/ZntA was amplified by 
PCR using 5’- GTC AGC GGC ATG GAC GCC GCG GCC GCT GCG CGC AAG 
GTA G-3’ as the forward primer and 5’-CTA CCT TGC GCG CAG CGG CCG 
CGG CGT CCA TGC CGC TGA C-3’ as the reverse primer. The clones were 
transformed into E.coli strains TG1 and deletion LMG194 (zntA::cat). All the 
genes were in frame with the hexa histidyl tag at the carboxyl terminal end.  
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Figure 3.3.  The location of restriction enzymes and the position of cysteine 
residues that are mutated. 
3.3.5 Expression and purification of the N terminal domain of ZntA (N1-
ZntA) 
BL21 (DE3) pLysS cells, transformed with N1-ZntA were grown at 37˚ C 
until the O.D600 was 1 and then induced with 0.1mM IPTG. Following induction 
the cells were grown for ~4 hours at 30˚ C. Harvested cells were resuspended in 
Buffer A (100 mM Tris, pH 8.0, 150 mM NaCl, 1mM EDTA) and stored at -20˚ C 
until further use. The frozen cell suspension was thawed and then disrupted at 
20,000 p.s.i. The cell lysate was incubated (~20ml) with DNase I (0.02mg/ml) 
and 2 mM MgCl2 and then centrifuged at 8000 rpm for 30 min, after which the 
supernatant was then centrifuged at 40,000 rpm for 1 h. Following centrifugation 
the supernatant was loaded onto a 5ml Strep-Tactin column that was pre-
equilibrated with 2 column volumes of Buffer A. The flow through was collected 
and reloaded on the column. After the cell extract completely entered the 
column, the column was washed 5 times with 1 column volume of Buffer A. The 
protein was eluted with Buffer B (Buffer A + 2.5 mM desthiobiotin, which is a 
reversible binding specific competitor). Fractions were collected and analyzed for 
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protein. Protein containing fractions were pooled and concentrated using 3K 
Amicon cut off concentrators.  
3.3.6 Expression and Purification of ZntA and ∆N- ZntA 
Both ZntA and ∆N-ZntA were expressed by growing the ZntA and ∆N- 
ZntA transformed LMG194 (zntA::cat) cells at 37˚ C in Luria-Bertani medium 
supplemented with 100µg/ml ampicillin to mid-log phase and then induced with 
0.02% arabinose. Cells were harvested 4 h after induction, washed with ice-cold 
buffer containing 25 mM Tris, pH 7 and 100 mM KCl, and stored at -20 ˚C until 
further use (50). The entire purification procedure was performed at 4˚C. The 
frozen cells were thawed and resuspended in buffer A (25 mM Tris, pH 7.0 with 
100 mM sucrose, 1 mM EDTA and 1 mM phenymethylsulfonyl fluoride (PMSF)) 
at 0.2 g/ml and disrupted at 20,000 p.s.i. The cell lysate was incubated with 
DNase I (0.02mg/ml) and 2 mM MgCl2 for 30 min. The cell lysate was then 
centrifuged at 8000 rpm for 30 min. The supernatant was centrifuged at 40,000 
rpm for 1 h to separate the membrane from the soluble cellular fraction. The 
pellet from the ultracentrifugation was resuspended in a low ionic strength buffer 
containing 2 mM Tris pH 7.0 with 100 mM sucrose and 1 mM EDTA, 1 mM 
PMSF. This removed the F1-ATPase from the membranes, which reduced the 
background ATPase activity that was not stimulated by soft metal ions. After the 
low ionic strength wash, the membranes were ultracentrifuged once again. The 
membranes were stored at 4˚C overnight. The membranes were then 
resuspended into Buffer C ( 25 mM Tris, pH 7.0, 100 mM sucrose, 500 mM 
NaCl) until  O.D280 = 1. Triton-X-100 was added dropwise to a final concentration 
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of 1% and the suspension was stirred at 4˚C for 1 h. The suspension was then 
centrifuged at 40,000 rpm for 1 h to separate the insoluble membranes. The 
Triton-X-100 solublized fraction was then loaded on a strep-tactin column that 
was pre-equilibrated with buffer D (buffer C + 0.2% Triton-X-100).The resin was 
subsequently washed with 25 ml of Buffer D. The protein was finally eluted with 
20 ml of buffer D containing 2.5 mM desthiobiotin. 1 ml fractions were collected 
and analyzed for protein. Protein containing fractions were pooled and loaded on 
a 40 ml Sephadex G-25 column pre-equilibrated with Buffer E (25 mM Tris pH 
7.0, 100 mM sucrose, 50 mM KCl, 0.2% Triton-X-100) to remove the 
desthiobiotin. 1 ml fractions were collected and assayed for protein. The protein 
containing fractions were pooled and concentrated using Centricon 
concentrators. The concentrated protein was then stored at -70˚C using glycerol 
as the cryoprotectant. 
3.3.7 Protein concentration determination 
Protein concentrations were determined using the bichinchonic acid reagent with 
bovine serum albumin as standard. 
3.3.8 Metal bound sample preparation for ATPase activity measurements 
and transport assays 
In assays where the N1-ZntA metal complex was used as the metal 
source, N1-ZntA protein was reduced with 1mM TCEP for 1 hour at 4 ˚ C. The 
reduced protein was then incubated with metal salts for 1 hour at 4˚ C; the 
excess metal was removed by passing through a Sephadex G– 25 column (56).  
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3.3.9 Measurement of Metal Concentration by ICP-MS 
The metal content was measured by a PE Sciex Elan 9000 ICP-MS 
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott 
type spray chamber. The RF power was 1000 W, and the argon flow was 
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium 
sensitivity. The data were collected as counts per second. Lead, Cadmium and 
Zinc standards were obtained from VWR. Standard calibration curves were 
determined from samples diluted from stock solutions of 1000 ppm standard 
solutions. The samples and standards solutions were all diluted in 2% HNO3. 
3.3.10 ATPase activity assay 
The metal dependant ATPase activity of the purified proteins (ZntA, ∆N-
ZntA) was assayed by the pyruvate kinase and lactate dehydrogenase coupled 
spectroscopic assay (50). In this assay, the ATP regeneration from ADP is 
coupled to the oxidation of NADH. The reaction was monitored at 340 nm for 20 
min. Prior to the assay the purified ZntA/∆N-ZntA was incubated with 2 mM 
dithiothrethiol (DTT) at 4˚C for 1 h. The assay buffer was made up of 0.1 M 
acetic acid, 0.05 M Bis Tris, and 0.05 M triethanolamine, pH 7.0. The reaction 
mixture also contained 0.1% purified asolectin, 0.1% Triton-X-100, 10% glycerol, 
5.0 mM each ATP and Mg(II), 0.25 mM NADH, 1.25 mM phosphoenolpyruvate, 
14 units of pyruvate kinase, and 20 units of lactate dehydrogenase, with or 
without lead, cadmium and zinc ions. To check the metal transfer from the N-
terminal region of ZntA (N1-ZntA) to the membrane region of ZntA, metal bound 
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N1-ZntA was used as a substrate for measuring the ATPase activity. Data were 
fitted to Michaelis-Menten equation.  
v = Vmax x S/ (KM + S) 
where, Vmax equals the maximum velocity, S is the concentration of metal/N1-
ZntA bound metal, KM is the Michaelis constant for the substrate. 
3.3.11 Transport Assays in everted membrane vesicles 
ZntA and ∆N cells were resuspended in Buffer A (25mM Tris, pH 7.0 with 
100mM sucrose, 1 mM EDTA and 1mM phenymethylsulfonyl fluoride (PMSF)) at 
0.2 g/ml and disrupted at 20,000 p.s.i. The cell lysate was incubated with DNase 
I (0.02 mg/ml) and 2 mM MgCl2 for 30 mins. Unbroken cells were removed by 
centrifugation at 8000 x g for 30 min. Membrane vesicles were pelleted by 
centrifugation at 40,000 x g for 60 min, washed and then resuspended in buffer 
containing 25 mM Bis-Tris pH 7.0, 250 mM sucrose and 500 mM NaCl. The 
resuspended pellets were frozen in aliquots and stored at -70˚C with glycerol as 
the cryoprotectant. The transport assays were performed at room temperature. 
The assay mixture contained 900 µl of 25 mM Bis-Tris, pH 7.0, 200 mM KCl, 250 
mM sucrose, 1–2 mg of membrane protein, 5 mM ATP or ADP, 10 µM 
lead/cadmium/zinc salts or metal bound N1-ZntA. The reaction was initiated by 
addition of 5 mM MgSO4. At intervals, 100 µl sample was withdrawn, filtered 
through pre-washed and blocked (blocked by washing with 1 ml of buffer 
containing 25 mM Bis-Tris, pH 7.0, 200 mM KCl, 250 mM sucrose and 10 mM 
MgSO4) 0.22 µm nitrocellulose filters. After the sample was filtered, the filters 
were washed with 5 ml of the above buffer and then dried. In order to measure 
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the metal content, the filters were completely digested in 300 µl of 70% 
concentrated HNO3 at 70˚C for 20 min. The samples were then diluted with 
HPLC grade water, and the total metal content was determined by ICP-MS. 
 
Figure 3.4. Transport Assay in everted membrane vesicles. 
3.3.12 Fluorescence Studies to monitor intermolecular crosslinking 
Energy transfer experiments were performed using N1-ZntA labeled with 
coumarin maleimide and ∆N-ZntA labeled with pyrene maleimide. The proteins 
were reduced with 1 mM TCEP for 1 hour at 4˚C and then incubated with ~2 fold 
excess fluorescent probes. The labeled proteins were then passed through 
Sephadex G-25 columns to remove the excess fluorophore. Labeling 
stoichiometries for each probe were calculated using the extinction coefficient of 
40,000 cm-1 M-1 for pyrene maleimide at 338 nm, and 33,000 cm-1 M-1 for 
coumarin maleimide at 384 nm (73). The fluorescence measurements were 
performed using a Photon Technology International spectrofluorimeter. Energy 
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transfer between ∆N-ZntA bound pyrene maleimide and N1-ZntA bound 
coumarin maleimide was followed in this experiment using the pyrene maleimide 
excitation wavelength of 340 nm and monitoring its emission in the absence and 
presence of labeled N1-ZntA.  
3.3.13 Fluorescence studies to monitor intramolecular crosslinking 
Single and double cysteine mutants that were purified with 0.05 mM 
dodecyl maltoside (DDM) instead of Triton-X-100 were reduced with 1mM TCEP 
and then incubated with 100-fold excess pyrene maleimide at room temperature. 
The excess pyrene was removed by passage through gel filtration Sephadex G–
25 columns pre-equilibrated with buffer containing 25 mM Tris, pH 7.0, 100 mM 
sucrose, 50 mM KCl and 0.05 mM dodecyl maltoside (DDM). Fractions were 
checked for protein by performing crude bichinchonic acid assays. The 
concentration of protein bound pyrene maleimide in the pooled fractions was 
measured using an extinction coefficient of 40,000 cm-1 M-1 at 340 nm. 
Fluorescence measurements were performed using Photon Technology 
International spectrofluorimeter. The samples were excited at 340 nm, and the 
emission spectrum recorded in the range 350-600 nm. Pyrene maleimide shows 
emission peaks at 376 nm and 396 nm (74-75). Pyrene also shows a 
characteristic excimer emission at ~470 nm when two pyrene molecules are 
within 4-6 Å of each other. The formation of this excimer was monitored (75). 
3.3.14 Competition Survival Assay 
The E.coli strains LMG194 (zntA::cat) transformed with pZntA and p∆N-ZntA 
were grown overnight at 37˚C in low-phosphate medium with either ampicillin 
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(100 µg/ml) or chloramphenicol (25 µg/ml). The overnight cultures were mixed in 
a 1:1 ratio, and diluted 1:100 in fresh low-phosphate medium containing 100 µg 
ampicillin and 50 µM zinc chloride, and grown at 37˚C overnight. Each morning, 
for 6 consecutive days, the overnight cultures were diluted 1:100 into fresh 
media and grown. Plasmids were extracted from the mixed culture, and equal 
amounts of DNA were analyzed by digestion with Nco1 and EcoR1. The 
digested DNA fragments were run on a 0.7% agarose gel containing 0.5 µg/ml 
ethidium bromide and observed at 302 nm.  
3.3.15 Sensitivity to metal salts 
The sensitivity of E.coli strains LMG194 and LMG194 (zntA::cat) and 
LMG194 (zntA::cat) transformed with pZntA, p∆N-ZntA, p∆N-N1 to lead, 
cadmium and zinc was measured. The cells were grown in low phosphate 
media, pH 7.5. Cells were grown overnight and then diluted 100 fold in the same 
media in the presence of lead acetate, zinc chloride, and cadmium chloride. Cell 
growth at 37 ˚C was monitored at 600 nm over a period of 24 hours. 
3.4 Results 
3.4.1 N1-ZntA confers a Competitive Advantage to ZntA 
From previous studies in the lab, it was observed that ∆N-ZntA is active in 
vivo but it grows more slowly compared to ZntA (56). To understand the 
importance of the N-terminal domain of ZntA in providing a survival advantage to 
ZntA, a competition survival experiment was performed (76). The E.coli strain 
LMG (zntA::cat), in which the ZntA gene had been deleted were used. These 
had either a plasmid with ZntA or ∆N-ZntA in the same vector. Equal amounts of 
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the two types of cells were mixed together and grown in the presence of 50 µM 
zinc in low phosphate medium. Each day the mixed culture was diluted 100 fold, 
and the amount of ∆N-ZntA and ZntA plasmids was analyzed by restriction 
enzyme digestion with Nco1 and EcoR1. Digestion of both plasmids produced a 
4.2 kbp fragment and a 2 kbp fragment for ZntA, and 1.8 kbp fragment for ∆N-
ZntA. After day 3, ∆N-ZntA completely disappeared (Figure 3.5). Thus, the 
presence of the N-terminal domain in the ZntA gene allowed it to competitively 
survive compared to a transporter lacking this domain. 
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Figure 3.5. Molecular competition between ZntA and ∆N-ZntA. 
Cells of E.coli strain LMG194(zntA::cat)  with either ZntA or ∆N-ZntA were grown 
in mixed culture for 9 days with daily dilutions into fresh ZAB medium in the 
presence of 50µM Zn. Equal amounts of DNA were separated by electrophoresis 
on a 0.7% agarose gel. The plasmids on Nco1 and EcoR1 digestion produced a 
4.1-kbp fragment of vector DNA, and a 2 kbp fragment of ZntA and 1.8 kbp 
fragment of ∆N. The restriction digestion fragments, of ZntA before growth (Lane 
2), ∆N (Lane 3), after day 1 (Lane 4), after day2 (lane 5), after day 3 (lane 6), 
after day 4 (lane 7), after day 5 (lane 8), after day 6 (lane 9), after day 7 (lane 8). 
 
3.4.2 The resistance profile of a co-expression vector in the presence of 
Pb2+, Cd2+, and Zn2+ 
With the observation that N1-ZntA provides a survival advantage to ZntA, 
we wanted to verify if it also provides a growth advantage when expressed as a 
separate domain. We constructed a co-expression plasmid which had both ∆N-
ZntA 
∆N 
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ZntA and N1-ZntA (∆N.N1). This was then cloned into an E.coli strain from which 
the entire zntA gene was deleted. The time courses of growth of wild type E.coli 
strain, LMG194, the zntA-deleted strain, LMG194(zntA::cat), and the deleted 
strain transformed with plasmids containing either a copy of the wtzntA gene, 
∆N, or  ∆N.N1 are shown in Figure 3.6. All the strains were able to grow in the 
presence of 10µM Pb2+, 50µM Zn2+, and 5µM Cd2+. When compared to the 
growth of ZntA, both ∆N-ZntA and ∆N.N1 grew slowly. The profile of ∆N.N1 was 
identical to that of ∆N-ZntA with respect to lead, cadmium and zinc. This may be 
because the N1-ZntA is not directly attached to ∆N-ZntA and therefore it does 
not provide an additional support to ∆N-ZntA for growth. 
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Figure 3.6. Resistance to lead, zinc, and cadmium salts by the wild type strains, 
LMG194 ( ), LMG194 (zntA::cat) (■), and the zntA deleted strain transformed 
with plasmids ZntA (▲), ∆N-ZntA(x), and ∆N.N1 (*). The cells were grown in low 
phosphate medium in the presence of 10 µM lead acetate, 50 µM zinc chloride, 
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and 5 µM cadmium chloride at 37˚C, and the cell growth was monitored at the 
mentioned time points by measuring the absorbance at 600 nm. 
3.4.3 ZntA and ∆N-ZntA membrane vesicles supplied with N1-ZntA-bound 
metal as the substrate, can catalyze ATP- dependent transport of lead, zinc 
and cadmium 
In this experiment we tested the ability of ZntA and ∆N-ZntA membrane 
vesicles to catalyze ATP dependent metal transport when the metal source was 
supplied as N1-ZntA bound form. Everted membrane vesicles were prepared 
from cells of ∆N-ZntA and ZntA. The metal source provided was in the form of 
metal bound N1-ZntA. In the absence or presence of an energy source (ATP) 
and metal bound N1-ZntA supplied as the substrate, uptake of 
zinc/lead/cadmium by the everted membrane vesicles of both ZntA and ∆N-ZntA 
was observed, only when ATP was present (Figure3.7). 
 
 
 
 
 
 
 
 
 
 
116 
 
0
1
2
3
4
5
6
7
0 2 4 6 8 10 12
 
 
0
1
2
3
4
5
6
0 2 4 6 8 10 12
 
 
0
0.5
1
1.5
2
2.5
3
3.5
0 2 4 6 8 10 12
 
                                            
Figure 3.7. ATP dependent metal uptake by everted membrane vesicles (Refer 
to Methods section 3.3.11 for detailed reaction conditions). In the absence of 
ATP no metal uptake was observed. 
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3.4.4 The transmembrane domain of ZntA and ∆N-ZntA, can catalyze ATP 
hydrolysis activity when the substrate is metal bound to the N-terminal 
domain 
Our hypothesis is that the cytosolic N-terminal domain binds to metal and 
transfers it directly to the transmembrane metal binding site. Lead, zinc, and 
cadmium stimulate ATP hydrolysis for both ZntA and ∆N-ZntA (50). To assess if 
the metal bound N-terminal domain can deliver metal ion to the catalytic pump 
and in turn activate the pump, the activity of the transporter was measured using 
metal bound N1-ZntA as the substrate. As shown in Figure 3.7, metal bound N1-
ZntA was a very good substrate for the membrane domain (∆N-ZntA). We 
wanted to measure and compare the kinetic parameters of ZntA and ∆N-ZntA 
using metal bound N1-ZntA as substrate. Earlier results, comparing the ATPase 
activity for ZntA and ∆N-ZntA showed that the activity of ∆N-ZntA was 2-3 fold 
lower than ZntA (56). Table 3.1 summarizes the kinetic parameters for ∆N-ZntA 
and ZntA for metal stimulated ATPase activity in the presence of 5mM MgCl2 
and ATP at pH 7.0 and 37˚C.Interestingly, when metal bound N1-ZntA was used 
as substrate, the activity of ∆N-ZntA was higher than when the substrates were 
free metal ions in buffer (Table 3.1). Also, the Vmax values were lower for ZntA 
than for ∆N-ZntA, a reversal of what is observed when free metal ions are used 
in the assay buffer. The lower values may be because ZntA already has an N-
terminal domain, and addition of metal bound N1-ZntA as substrate leads to the 
two metal binding sites (the transmembrane metal binding site and the cytosolic 
metal binding site) competing for the metal ion.  
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Table 3.1. Kinetic parameters obtained for ∆N-ZntA and ZntA for Pb2+, Cd2+ and 
Zn2+as free species in buffer and in the N1-ZntA bound form.  
 
 ∆N-ZntA ZntA 
Vmax 
(nmol.mg1.min-
1) 
app KM 
(µM) 
Vmax 
(nmol.mg1.min-1) 
app KM 
(µM) 
Pb(II) 320 ± 6 11.6 ± 0.8 560 ± 13 5.6 ± 0.6 
N1-ZntAPb(II) 404 ± 11 0.8 ± 0.07 250 ± 8.3 0.3 ± 0.04 
Cd(II) 66 ± 3 4.1 ± 0.6 60 ± 3 5.5 ± 1.2 
N1-ZntACd(II) 300 ± 7.5 0.25 ± 
0.022 
147 ± 8.6 0.36 ± 
0.064 
Zn(II) 81 ± 7 9.3 ± 1.2 250 ± 13 10.3 ± 2 
N1-ZntAZn(II) 270 ± 14 0.47 ± 0.06 166 ± 7.2 0.3 ± 
0.035 
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 Figure 3.8. ∆N-ZntA ATPase Activity in the presence of Pb2+ (A) and N1-
ZntA bound Pb2+ (B). 
 
B) ∆N + [N1-ZntA-Pb2+] µM 
Vm = 404 ± 11 nmol.mg1.min-1 
KM = 0.8 ± 0.07 µM 
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Figure 3.9. ZntA ATPase Activity in the presence of Pb2+ (A) and N1-ZntA bound 
Pb2+. 
A) ZntA ± [Pb2+] µM 
Vm = 560 ± 13 nmol.mg1.min-
1
 
B) ZntA ± [N1-ZntA-Pb2+] µM 
Vm = 250 ± 8.3nmol.mg1.min-1 
KM= 0.3 ± 0.04 µM 
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3.4.5 Interaction of N1-ZntA with ∆N-ZntA  
Whether a direct interaction between the two metal binding sites in N1-
ZntA and ∆N-ZntA is feasible or not was examined by an energy transfer 
experiment. Both sites contain cysteine residues. Therefore, the cysteines in N1-
ZntA were labeled with coumarin maleimide and that in ∆N-ZntA was labeled 
with pyrene maleimide. Both are cysteine specific reagents and are essentially 
non-fluorescent until they react with thiols. Coumarin maleimide has an emission 
maximum at 469 nm when excited at 384 nm (73). The absorption maximum for 
pyrene is around 340 nm. Its emission maximum is usually a doublet peak at 
about 376 and 396 nm. When two pyrene molecules are spatially close, they can 
form an excimer, with a broad emission spectrum centered at about 470 nm. In 
this experiment, the fluorescence resonance energy transfer between the 
coumarin maleimide labeled N1-ZntA and pyrene maleimide labeled ∆N-ZntA 
was observed, in which the emission energy from pyrene was transferred to 
coumarin. The mixture of coumarin maleimide labeled N1-ZntA and pyrene 
labeled ∆N-ZntA was excited at 340 nm (excitation emission peak of pyrene); a 
characteristic coumarin emission peak at 470 nm was observed (Figure 3.10). 
Therefore, coumarin could be excited by transfer of emission energy from the 
pyrene emission spectrum, which overlaps with the coumarin excitation 
spectrum. This indicates that the two domains, N1-ZntA and ∆N-ZntA can come 
close to each other for this energy transfer to occur.  
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Figure 3.10. Fluorescence resonance energy transfer from Pyrene maleimide 
labeled ∆N-ZntA (peak at 370 and 390 nm) to coumarin maleimide labeled N1-
ZntA  (peak at ~ 470 nm) using an excitation wavelength of 340 nm.  
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3.4.6 Proximity of the two metal binding domains binding sites 
 
Figure 3.11. Model showing cysteine residues in ∆46-ZntA. 
 
As mentioned earlier, ZntA has two metal binding sites; one in the 
transmembrane region and the other in the cytosolic N-terminal domain. Both the 
metal binding sites have conserved cysteine residues (CPC and CXXC). Since 
the results of the ATPase activity assay and transport assay have shown that 
metal bound to N1-ZntA can be transferred to the membrane site, our hypothesis 
is that the cysteine residues of the two metal-binding sites come close to each 
other for metal transfer to occur. To examine the proximity of the cysteine 
residues in the two domains we used the property of pyrene to form excimer with 
a characteristic fluorescence emission spectrum. We constructed mutants in a 
truncated form of ZntA called ∆46-ZntA (the first 46 residues of ZntA were 
deleted); this construct was used because the two cysteine containing metal 
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binding sites were intact and the four upstream cysteine residues were absent. 
This helped in generation of mutants in which either one or two cysteines were 
present in the entire protein. The double mutants were ∆46-
C59A/C62/C392A/C394/ZntA, ∆46-C59A/C62/C392/C394A/ZntA, ∆46-
C59/C62A/C392A/C394/ZntA, ∆46-C59/C62A/C392/C394A/ZntA. Single mutants 
were created for controls; these were ∆46-C59A/C62/C392A/C394A/C518A/ZntA 
and ∆46-C59A/C62A/C392A/C394/C518A/ZntA. Each of these mutant proteins 
was labeled with pyrene maleimide at room temperature. The labeling ratios for 
each of the double mutants are ~ 2 and each of the single mutants is ~ 1. This 
was determined using the known extinction coefficient for pyrene maleimide. The 
maximum absorbance peak for these mutants was around ~340 nm. When the 
emission spectra for these mutants were measured, the characteristic pyrene 
peaks at 375 nm and 390 nm were observed; additionally a small, broad peak 
centered at ~ 480 nm was observed for double cysteine mutants. This emission 
peak is indicative of a pyrene excimer which is formed only when the two pyrene 
molecules interact within a distance of 6-10 Å. As a control, the single cysteine 
containing proteins when subjected to similar reaction conditions, did not display 
the characteristic pyrene excimer. This control experiment indicates that the 
excimer formation is not due to dimerization of the mutant proteins. The excimer 
formation indicates that the cysteines in the two metal binding sites in ZntA can 
approach within 6-10 Å of each other. 
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Figure 3.12. Emission spectra of pyrene maleimide labeled ∆46-ZntA cysteine 
mutants. 
3.5 Discussion 
Metal binding to the transmembrane region is an essential part of the 
ATPase reaction mechanism. ZntA, a PIB2 type ATPase involved in lead, zinc 
and cadmium transport, has a hydrophilic N-terminal domain. This domain has a 
conserved CXXC motif that has been shown to bind metal ions, which is 
conserved in the copper chaperone proteins like Atx1, Atox1, and CopZ. To date 
there has been no evidence of metallochaperones involved in zinc homeostasis 
and lead and cadmium detoxification. The aim of this work was to test our theory 
that the N-terminal domain acts an attached chaperone to the transporter; the N-
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terminal domain efficiently binds metal ions from the cytosol and then directly 
delivers them to the metal binding site in the transmembrane region. 
 Early studies in the lab have shown that deletion of the entire N-terminal 
domain of ZntA does not inactivate the transporter; also its metal specificity is 
not affected (56). In vivo results show ∆N–ZntA is able to complement the Pb2+, 
Zn2+ and Cd2+ sensitivity of a zntA deleted strain, but the growth rate is slower 
than ZntA. To investigate this further, we compared the ability of ZntA and ∆N-
ZntA to confer survival advantage to E.coli in toxic metal concentrations. In a 
competition assay, by day 3, only cells with ZntA survived (Figure 3.4), indicating 
that presence of the N-terminal domain gave ZntA a competitive advantage for 
survival in the presence of zinc. Additionally we also constructed a vector where 
both ∆N-ZntA and N1-ZntA were co-expressed. The co-expression vector has a 
similar resistance profile (Figure 3.5) to ∆N-ZntA, indicating that the N-terminal 
domain needs to be directly attached to the rest of the transporter in vivo, for it to 
display any growth advantage in the presence of toxic concentrations of lead, 
cadmium and zinc.  
In vitro, the activity of truncated protein (∆N-ZntA) is 2-3 fold lower than 
that of ZntA (56). ICP measurements on N1-ZntA and ∆N–ZntA have shown that 
both sites bind metal ions with a stoichiometry of 1; also the metal affinities for 
both the sites are similar. These results suggest that metal ion transfer between 
the two domains is feasible. If the N1-ZntA does deliver metal ions directly to the 
membrane region, the two metal binding sites in the N-terminal domain and 
transmembrane domain must come close to each other and interact for metal 
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transfer to occur. To investigate this we used cysteine specific fluorophores. 
Coumarin maleimide and pyrene maleimide were used to examine the 
interaction between the two domains. N1-ZntA labeled with coumarin maleimide 
was added to ∆N-ZntA labeled with pyrene maleimide; this mixture was excited 
at 340 nm and showed an emission peak at ~470 which is characteristic of 
coumarin maleimide, in addition to the expected pyrene maleimide emission 
peak. The coumarin emission peak was observed because the emission energy 
from pyrene labeled ∆N-ZntA was transferred to the coumarin labeled N1-ZntA, 
indication that the two domains can approach close in our in vitro assays (Figure 
3.10). To examine the proximity of the two metal binding sites in the full-length 
ZntA, we made double and single cysteine mutations in a truncated form of ZntA 
(∆46-ZntA) where the first 46 residues were deleted (Figure 3.11). These 
mutants were labeled with pyrene maleimide, a thiol specific fluorophore. When 
the labeled mutants were excited at 340 nm, the emission spectra for double 
mutants showed a peak at 480 nm which corresponds to characteristic excimer 
emission peak for pyrene maleimide (Figure 3.12). This excimer or “excited state 
dimmer” is formed due to the interactions between the excited state of one 
monomer and the ground state of a second monomer (77). Distance and 
orientation are the two reasons that lead to formation of pyrene excimer. The 
pyrene excited state monomer must be with 6-10Å to interact with the ground 
state monomer and after excitation the monomers must orient themselves in the 
correct way or else the fluorescence will be quenched. This is a very useful 
method to examine the distance between the two sites. The excimer formation 
128 
observed for the pyrene labeled double cysteine mutants demonstrates that the 
two metal binding domains come close to each other and should be able to 
facilitate metal transfer. 
 A major goal of this work was to look at metal transfer by the N-terminal 
domain to the membrane region, by metal uptake assays using everted 
membrane vesicles of ∆N-ZntA and ZntA and also ATPase activity 
measurements. In both the experiments the metal substrate provided was metal 
bound N1-ZntA. Everted ∆N-ZntA and ZntA membrane vesicles both exhibited 
ATP dependent lead, zinc and cadmium accumulation by using metal bound N1-
ZntA as the metal substrate (Figure 3.7). The everted membrane vesicles have 
an orientation opposite to that of intact cells; metal accumulation into the vesicle 
is same as extrusion from cells (Figure 3.3). Also, metal loaded N1-ZntA was 
used in the ATPase activity assay. Pb2+, Zn2+ and Cd2+ loaded N1-ZntA 
stimulated the ATPase activity of the transporter. A comparison of the Vmax and 
Km parameters for the ATPase activities of ∆N-ZntA and ZntA in the presence of 
metal bound N1-ZntA as the substrate with those in the presence of free metal 
ion as substrate shows that the metal bound N1-ZntA stimulated activities of ∆N-
ZntA were higher than free metal stimulated activities of ∆N-ZntA. But in the case 
of ZntA the activities in the presence of metal bound N1-ZntA was lower than in 
the presence of free metal. This may be because the intact N-terminal domain in 
ZntA has to first acquire metal ion from the N1-ZntA and then transfer it to the 
metal binding site in the membrane; this extra step slows down the rate. It is 
possible that for full-length ZntA, the attached N-terminal domain does not allow 
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the N1-ZntA fragment from delivering metal ion directly to the transmembrane 
site. 
 All the experiments shown here point towards the fact that the N-terminal 
metal site of ZntA comes within a distance of 6-10 Å of the transmembrane site 
to deliver metal ions to the membrane transport site (Figure 3.13). The amino 
terminal domain of ZntA is important for survival; it functions as an attached 
chaperone to the transporter and thus makes the process of metal binding and 
hence, transport, more efficient. 
 
 
Figure 3.13. Model for Metal delivery to transmembrane metal binding site in 
ZntA. 
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CHAPTER 4 
CHARACTERIZING THE METAL BINDING PROPERTIES OF A TRUNCATED 
FORM OF ZNTA THAT IS STRUCTURALLY SIMILAR TO THE PINEAL NIGHT 
SPECIFIC ATPASE ENCODED BY A SPLICE VARIANT OF THE WILSON 
DISEASE GENE, ATP7B 
 The work presented in this chapter is preliminary in nature. The 
experiments performed involve characterizing a truncated form of ZntA that lacks 
the first 4 transmembrane helices. 
4.1 Introduction  
 
Figure 4.1.Membrane Topology of PIB and P2/P3 ATPases. 
ZntA has two metal binding sites, one in the N-terminal region and the 
other in the transmembrane region (63). The transmembrane metal site is 
essential for activity of the pump. All PIB ATPase family members have eight 
transmembrane helices and a few characteristic conserved charged residues in 
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the transmembrane region depending on the specific subgroup. All PIB ATPases 
contain a conserved motif (C, S, T) P(C, H) in helix 6 (45). In the PIB-1 subfamily, 
which is selective for Cu+, Ag+, and the PIB-2 subfamily, which is selective for  
Pb2+, Zn2+ and Cd2+, the motif is conserved as CPC. Previous work in our 
laboratory on the conserved motif CPC has demonstrated that the alanine 
mutations at each of the two cysteine residues resulted in complete loss in 
activity and the proteins were also unable to bind metal ion at the 
transmembrane metal binding site, indicating that each of the cysteine residues 
are important metal-binding ligands (55).  
 Sequence alignment of helix 8 for P1B-type ATPases shows the presence 
of a strictly conserved aspartate residue in the PIB-2 subfamily, which is not 
conserved in any other subgroup of the PIB-ATPases. However this aspartate 
residue is strictly conserved in the transmembrane helix 6 of P2 and P3 family of 
ATPases, which corresponds to helix 8 in PIB-ATPase (62) (Figure 1). Previous 
work from our laboratory has shown that Asp714 in ZntA residue is essential for 
the overall activity of the protein and it provides ligands to metal ions in the 
transmembrane site (62). Studies on the corresponding conserved Asp residue 
in the calcium ATPase, which belongs to the P2A family, has shown that this 
residue is essential for activity of the pump. Structural studies on the calcium 
ATPase has shown the aspartate residue acts as a bridge to the two Ca2+ ions in 
the membrane (40). In other members of the P2 family such as the Na+/K+ 
ATPase and the H+/K+ pumps mutation of this aspartate residue leads to loss in 
activity of the protein (78). In the plasma membrane proton pumps which belong 
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to the P3 family of ATPases, the aspartate residue is involved in conformational 
change of the transporter during catalysis (62).  
 Thus, in the ZntA subgroup of P1B-type ATPases, both the CPC motif in 
helix 6 and the Asp in helix 8 are part of the metal binding site in the 
transmembrane domain; these residues are involved in conferring metal 
selectivity to the pump.  
 The pineal gland is an endocrine organ of the brain that is responsible for 
the synthesis and secretion of melatonin mainly at night (79). Experiments to 
investigate the pineal circadian rhythms led to the identification of a novel protein 
called pineal night-specific ATPase (PINA), a night-specific and pineal/retina-
specific splice variant of the ATP7B gene, defects in which cause Wilsons 
disease (80). Wilsons disease is an inherited disorder related to copper 
transport; it leads to accumulation of copper in the liver and hence, toxicity (20). 
Copper is also accumulated in the brain and is thought to be responsible for 
neurological and psychiatric abnormalities in some Wilson disease patients (20). 
The gene for Wilsons disease encodes a copper transporting ATPase (ATP7B), 
which belongs to the PIB-1 subfamily of PIB ATPases, which are selective for Cu+ 
and Ag+. From sequence analysis it was observed that PINA is identical to the C-
terminal half of ATP7B (79). The 5’ region upstream of the open reading frame of 
PINA has a 300 bp sequence which is not found in ATP7B and is pineal specific 
(79). Unlike ATP7B, PINA lacks the entire N-terminal domain which contains six 
CXXC motifs that are involved in copper binding. Also the first four 
transmembrane helices are absent (79). PINA however still retains some 
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important elements of P-type ATPases such as the phosphorylation domain, the 
ATP binding domain and the conserved CPC motif, which is important in metal 
binding in both the PIB-1 and PIB-2 subfamilies. Indirect in vivo studies suggested 
that although the N-terminal copper binding region and half the transmembrane 
helices are absent, the PINA protein may be able to transport copper in a yeast 
system but at a much lower efficiency than the ATP7B (79-80); however no 
direct proof exists that the PINA protein is an active transporter. So far, very little 
is known about the role of the first four transmembrane helices in PIB ATPases; 
helices 3 and 4 correspond to helices 1 and 2 in the Ca2+ ATPase. In the Ca2+ 
ATPase, helices 1-5 undergo major structural changes on metal binding and 
phosphorylation (37). With the discovery of PINA, we wanted to test a similar 
truncated form of ZntA that lacked the amino terminal domain and the first four 
transmembrane helices, Del231-ZntA, in order to investigate if the loss of 
upstream four transmembrane helices would affect the activity and the metal 
binding ability of the transporter. 
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Figure 4.2.Structure of PINA in comparison with ATP7B. PINA is made up of 
3.5kb (PINA5.1) and 4.3(PINA5.2) transcripts that are similar to the C-terminal 
portion of ATP7B. The regions conserved in the copper transporters are: Metal: 
metal binding domains (CXXC motifs); Td:transduction domain (TGEA); 
Ch/Ph:metal binding, CPC motif; phosphorylation domain (DKTGT); ATP:ATP-
binding domain (GDGXNDXP) (79). 
 
 
Figure 4. 3. Structures representing ZntA and the truncated form, Del231-ZntA 
4.2 Materials  
 Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained 
from Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the 
ATPase activity assay and standard metal solutions were purchased from 
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Sigma. Metal standards used for inductively coupled plasma mass spectrometry 
(ICP-MS) were from VWR. 
4.3 Methods 
4.3.1 Construction of Del231-ZntA with a carboxyl-terminal His tag and 
carboxyl terminal strep tag 
Del231-ZntA with a 6 His tag was created by PCR using the plasmid ∆N-
ZntA as template and the oligonucleotides 5’-CGT GCC ATG GCG CTG AAA 
CC- 3’ as forward primer and 5’-GAA TTC TCT CCT GCG CAA CAA TCT TTA 
ACG-3’ as the reverse primer. The PCR product and the vector were digested 
with Nco1 and EcoR1, after which the amplified DNA fragment and the vector 
were ligated together to generate his tagged Del231-ZntA.  
Strep tagged Del 231-ZntA was created by using the plasmid ∆N-ZntA as 
template and the primers 5’-CGT GCC ATG GCG CTG AAA CC- 3’ as forward 
primer and 5’ GCG CTC GAG TTA TTT TTC GAA CTG CGG GTG GCT CCA 
CAG GGA ATA GCC TGC 3’ as the reverse primer. The PCR product and the 
vector were digested with Nco1 and EcoR1, after which the amplified DNA 
fragment and the vector were ligated together to generate strep tagged Del231-
ZntA. The sequence of both Del-ZntA with the C-terminal his tag and C-terminal 
strep tag were confirmed using DNA sequencing analysis; both the genes were 
in frame with the corresponding tags at the carboxyl terminus. 
4.3.2 Protein expression of Del231-ZntA (his tag and strep tag) 
Both the His-tagged and strep tagged Del231-ZntA were expressed by 
growing LMG194 (zntA::cat) transformed with Del231-ZntA at 37˚ C in Luria-
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Bertani medium supplemented with 100 µg/ml ampicillin to mid-log phase and 
then induced with 0.02% arabinose. Cells were harvested 4 h after induction, 
washed with ice-cold buffer containing 25 mM Tris, pH 7 and 100 mM KCl, and 
stored at -20˚C till further use (50).  
4.3.3 Protein Purification of Del231-ZntA 
Protein purification procedures were all performed at 4˚C. Frozen cells 
were thawed and resuspended in buffer A (25 mM Tris, pH 7.0, 100 mM 
sucrose, 1 mM PMSF, 1 mM EDTA and 1 mM β-mercaptoethanol (BME)) at 
0.2g/ml. The cells were broken at 20,000 p.s.i with a French press, the lysed 
cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30 min. 
The lysed cells were then centrifuged at 8000 rpm for 30 min. The supernatant 
was then centrifuged at 40,000 rpm for 1 h to separate the membranes from the 
soluble fraction of cells. The pellet from this centrifugation was resuspended in 
buffer B (1 mM Tris pH 7.0, 100 mM sucrose, 1 mM EDTA, 1 mM PMSF, and 1 
mM BME), stirred for 1 hr at 4˚C, and then centrifuged at 40,000 rpm for 1 h. The 
membrane fraction was resuspended in buffer C (25 mM Tris pH 7.0, 100 mM 
sucrose, 500 mM NaCl, 1 mM PMSF and 1 mM BME). Triton-X-100 was added 
to a final concentration of 1% and the suspension was stirred for 1 h at 4˚C. The 
solublized membranes were then centrifuged at 40,000 rpm for 1 h to remove 
the insoluble fraction.  
For the His tagged protein: The supernatant was then loaded on a charged Ni2+-
pro-bond column. The column was washed successively with buffer C, buffer C + 
50 mM imidazole, buffer C + 100 mM imidazole. Finally the protein was eluted 
140 
using 30 ml of buffer C with 300 mM imidazole. 1ml fractions were collected and 
analyzed for protein. Protein containing fractions were pooled and loaded on 40 
ml Sephadex G-25 columns to remove imidazole. Protein fractions were 
collected and concentrated using YM-100 centricons. The protein was stored at -
80˚C with 10 % glycerol as a cryoprotectant.  
For the Strep tagged protein: The Triton-X-100 solublized fraction was 
loaded on a strep-tactin column that was pre-equilibrated with buffer D (buffer C 
+ 0.2% Triton-X-100). The resin was subsequently washed with 25ml of Buffer D. 
The protein was finally eluted with 20ml of buffer D containing 2.5 mM 
desthiobiotin. 1 ml fractions were collected and analyzed for protein. Protein 
containing fractions were pooled and loaded on a 40 ml Sephadex G-25 column 
pre-equilibrated with Buffer E (25 mM Tris pH 7.0, 100 mM sucrose, 50 mM KCl, 
0.2% Triton-X-100) to remove the desthiobiotin. 1ml fractions were collected and 
assayed for protein. The protein containing fractions were pooled and 
concentrated using Centricon concentrators. The concentrated protein was then 
stored at -70˚C using glycerol as the cryoprotectant. 
4.3.4 Determination of Protein Concentration 
Protein concentrations were determined by the bichinchonic acid assay, 
using bovine serum albumin as standard. This assay is a modified Lowry assay, 
where the proteins reduce Cu2+ to Cu+ in a concentration dependent manner. 
Bichinchonic acid forms a purple complex with Cu+, which has an absorbance 
maximum at 562 nm. This absorbance is proportional to the protein 
concentration. BSA is used to generate a standard curve. 
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4.3.5 Sensitivity to metal salts 
The sensitivity of E.coli strains LMG194, LMG194 (zntA::cat) and LMG194 
(zntA::cat) transformed with pZntA or Del231-ZntA, to lead, cadmium and zinc 
was measured. The cells were grown in low phosphate media, pH 7.5. Cells 
were grown overnight and then diluted 100 fold in the same media in the 
presence of lead acetate, zinc chloride, and cadmium chloride. Cell growth at 37 
˚C was monitored at 600 nm over a period of 24 hours (56, 69). 
4.3.6 ATPase Activity Measurements 
The activity of Del231-ZntA was measured by a coupled spectroscopic 
assay, involving pyruvate kinase and lactate dehydrogenase. The regeneration 
of ATP is coupled to the oxidation of NADH, which is monitored at 340 nm (50). 
The buffer for the reaction was 0.05 M Bis tris, 0.1 M acetic acid, and 0.05 M 
triethanolamine at pH 7.0. The reaction mixture (1 ml) also contained 0.1% 
asolectin, 0.2% Triton–X–100, 10 % glycerol, 5 mM ATP, 0.25 mM NADH, 1.25 
mM phosphoenolpyruvate, 7 units of pyruvate kinase, and 10 units of lactate 
dehydrogenase, with or without metal ion (Zn2+, Pb2+, Cd2+). The proteins were 
reduced by incubation with 2 mM DTT for 1 h prior to the reaction. About 0.5-2 
mg/ml protein was used per assay. The reaction mixture was incubated for 5 
mins at 37˚C before initiating the reaction with 5 mM MgCl2.  
Thiolates in the assay buffer are known to increase the ATPase activity 
(50). The activity of the mutant was also investigated in the presence of thiolates. 
Along with the other assay ingredients, thiolates were also added. The 
concentration of the thiolate form of cysteine required to generate a constant 
142 
metal ion: thiolate ion ratio was calculated using the Henderson-Hasselbach 
equation, using a pKa of 8.33 for cysteine and a pH of 7.0. The data obtained 
was fit to the Michaelis-Menten equation, 
v = Vmax x S/ (KM + S) 
where, Vmax equals the maximum velocity, S is the concentration of metal, KM is 
the Michaelis constant for the substrate metal ion (50). 
4.3.7 Preparation of Metal bound Del231-ZntA 
To measure the stoichiometry of metals bound to Del231-ZntA, the 
protein was reduced with 1 mM TCEP for 1 h at 4 ˚C. The reduced protein was 
then incubated with metal salts for 1 hour at 4 ˚C, and then excess metal was 
removed by passing through a Sephadex G–25 column (56).  
4.3.8 Measurement of Metal Binding Stoichiometry of Del231-ZntA by ICP-
MS 
The metal content was measured by a PE Sciex Elan 9000 ICP-MS 
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott 
type spray chamber. The RF power was 1000 W, and the argon flow was 
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium 
sensitivity. The data were collected as counts per second. Lead, Cadmium and 
Zinc standards were obtained from VWR. Standard calibration curves were 
determined from samples diluted from stock solutions of 1000 ppm standard 
solutions. The samples and standards solutions were all diluted in 2% HNO3. 
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4.4 Results 
4.4.1 The in vivo resistance activity of Del2310ZntA mutant to Pb2+, Zn2+ and 
Cd2+ in the growth medium 
 The zntA deleted E.coli strain, LMG194 (zntA::cat) is sensitive to toxic 
levels of Pb2+, Zn2+ and Cd2+; it is unable to grow even after 24-30 h and this 
sensitivity can be complemented by wtzntA. However when this zntA deleted 
strain was complemented with the del231-zntA gene, it was unable to confer 
resistance to Pb2+, Zn2+ and Cd2+. 
 
Figure 4.4. Resistance to Lead, Zinc and Cadmium salts by the wild type strain 
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain 
transformed with plasmids containing wtzntA and del231-ZntA.The strains were 
grown in the presence of varying metal concentrations and the absorbance was 
measured after 24 hours. 
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4.4.2 Activity of the purified Del231-ZntA 
The ATPase activity of Del231-ZntA and ZntA was measured for the metal 
ions Pb2+, Zn2+ and Cd2+. Previous studies showed that the metals ions stimulate 
the ATP hydrolysis activity of wtZntA, with Pb2+ exhibiting the highest activity 
(50). Del231-ZntA did not show any metal induced ATPase activity. There is a 4-
8 fold increase in the ATPase activity of ZntA in the presence of thiolate forms of 
cysteine or glutathione in the assay medium (50). The activities for wtzntA and 
Del231-ZntA were measured in the presence of metal ions and thiolate form of 
cysteine in the ratio 1:1 for Pb2+, Zn2+ and Cd2+. The Del231-ZntA showed 
extremely small but measurable activities in the presence of the thiolate form of 
cysteine (Table 4.1). 
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Table 4.1. Kinetic Parameters obtained for ZntA and Del231-ZntA, in the 
presence of the thiolate form of cysteine present at a concentration equal to the 
M2+ concentration. 
 Pb2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 2500 ± 70 166 ± 16 
Del231-
ZntA 
15 ± 0.6 109 ± 15 
 Zn2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 710 ± 28 96 ± 11 
Del231-
ZntA 
5 ± 0.16 45 ± 7.2 
 Cd2+ + Thiolate 
Vmax 
nmoles/mg/min 
KM 
µM 
ZntA 1025 ± 25 252 ± 16 
Del231-
ZntA 
2 ± 0.11 53 ± 12 
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4.4.3 Stoichiometry of Metal Binding to Del231-ZntA using ICP-MS 
Del231-ZntA has the conserved metal binding motif (CPC) and the 
conserved Asp714 (original ZntA numbering). To investigate if the truncated 
protein was able to bind metal ions, we determined the metal binding 
stoichiometries of the truncated protein purified with a strep-tag. Wild-type ZntA 
can bind to two metal ions with high affinity. ∆N-ZntA which lacks the amino 
terminal domain, binds to Pb2+, Zn2+ and Cd2+ with a stoichiometry of 1. It was 
observed that Del231-ZntA bound to Pb2+, Zn2+ and Cd2+ with a stoichiometry of 
0.5.  
Table 4.2. Stoichiometry of Metal bound to N1-ZntA and Del231-ZntA using 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
 Lead Zinc Cadmium 
ZntA 2 ± 0.0 2 ± 0.1 2 ± 0.0 
∆N-ZntA 1 ± 0.1 1 ± 0.0 1 ± 0.0 
Del231-ZntA 0.5 ± 0.0 0.5 ± 0.1 0.5 ± 0.0 
 
4.5 Discussion 
Most P-type ATPases contain metal binding motifs (CXXC, histidine and 
methionine rich motifs) in their amino terminal domains. Transporters in the 
Zn2+/Pb2+/Cd2+ and Cu+/Ag+ subgroups all have an N-terminal metal-binding 
domain containing 1-6 copies of the CXXC motif. Both these subgroups also 
have the CPC motif in TM 6, and a conserved Asp in TM 8 for the Zn2+/Pb2+/Cd2+ 
subgroup. So far, our investigation showed that these three residues are 
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involved in binding the metal ion in the transmembrane domain and conferring 
selectivity to the bound metal in ZntA. The function of the first four TM helices in 
the P1B-type ATPases is unclear; also it is not known whether they contribute to 
metal binding or not. They do not have any conserved residues that are polar. In 
order to test whether TMs 5-8 were adequate in metal binding and transport, we 
created a truncated form of ZntA which is similar to PINA. In vivo, Del231-ZntA 
did not confer resistance to Pb2+, Zn2+and Cd2+; its resistance profile was similar 
to the zntA deleted strain, indicating that both the amino terminal and the first 
four transmembrane helices are necessary for growth and survival. The 
truncated protein did not display any activity in the presence lead, zinc and 
cadmium. When the metal thiolate complex was used as the substrate, very low 
levels of activity were observed. Given that the in vitro activity of del231-ZntA is 
very low compared to ZntA, it is not surprising that in vivo, this truncated mutant 
is unable to provide resistance to metal salts. 
However, the fact that some activity was observed in vitro, suggested to 
us that Del231-ZntA would be able to bind metal ions. Our results show that 
Del231-ZntA was indeed able to bind lead, zinc and cadmium, but surprisingly, 
with a stoichiometry of 0.5, unlike ∆N-ZntA, which binds metal ions with a 
stoichiometry of 1. This result shows that TMs 5-8 are able to bind metal ions 
without the presence of TMs 1-4. It is possible that TMs 1-4 provide a fourth 
metal binding ligand, which when absent, forces the transporter to dimerize, with 
a second monomer providing the fourth ligand, leading to a stoichiometry of 0.5. 
It is also possible that TMs 1-4 do not provide a metal-binding ligand, but in their 
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absence, the transmembrane region folds in such a way that the transporter is 
able to dimerize easily in the membrane region, and therefore accommodates 
only one metal ion per dimer, again resulting in a stoichiometry of 0.5. Further 
studies are needed to show whether the CPC motif as well as Asp714 are all 
metal ligands in Del231-ZntA, and whether the metal binding affinity in Del231-
ZntA is similar to that of ZntA or ∆N-ZntA. It is clear though, that the first four 
transmembrane helices of ZntA are necessary for high activity of the transporter, 
and hence, growth in vivo in the presence of toxic concentrations of Pb2+, Zn2+ 
and Cd2+. This suggests that the PINA protein may not be a good Cu+ 
transporter, but may be able to bind and transfer Cu+ to other Cu+-binding 
proteins, especially membrane-bound Cu+-binding proteins. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
The major aims of this thesis have been to study the structural, and 
biochemical aspects of ZntA which has given us an insight into the different 
mechanisms adopted by metal transporting proteins to achieve metal selectivity. 
I have been able to answer some of the many questions by characterizing the 
conserved cysteine residues (CCCDXXC and GMDCXXC) in the cytoplasmic N-
terminal domain of ZntA and the interaction of this domain with the core 
transporter. This work is presented in Chapters 2 and 3. We began by altering 
the individual cysteine residues to alanines and the individual aspartate residues 
to alanine and asparagine. These mutants were fully characterized for in vivo 
resistance, ATPase activity, lead, zinc and cadmium binding (Fluorescence 
spectroscopy, ICP-MS) and the lead, zinc, cadmium binding site structures were 
examined by XAS. Our results suggested that Cys31 from the CCCDXXC motif, 
as well as the GMDCXXC conserved motif play important roles in metal 
selectivity to metal ions of highly different sizes.  
Research presented in Chapter 3 sheds light on the role of the N-terminal 
domain as an attached chaperone to the core transport domain. The interaction 
between the two domains has been characterized using vivo assays, FRET 
studies; ATPase activity measurements. From the results obtained we can 
conclude that the amino terminal domain of ZntA is important for survival and it 
efficiently transports metal ion to the membrane domain.  
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In ongoing studies, solving the structure of the Pb2+-bound N-terminal 
domain will give us detailed structural information about the positions of the two 
cysteine-rich motifs in this domain. So far there is no available structural data 
with regards to the metal binding site in the transmembrane domain of ZntA; X-
ray absorption studies on the metal bound form of ∆N-ZntA will provide us an 
insight into ligand environment and geometry. Within the cell, other than 
metalloproteins, there are several small-molecule chelating agents; we have 
studied the effect of two such agents (glutathione and cysteine) on the ATPase 
activity of ZntA. The metal:thiolate complex increases the activity of the 
transporter 4-5 fold. Another aspect to study would be to look at the effect of 
different chelating agents (citrate, histidine, imidazole etc) on the activity of the 
transporter in order to learn if metal complexes of sulfur-containing chelators 
behave differently from those of oxygen or nitrogen-containing chelators with 
respect to being efficient substrates of ZntA.. 
The fourth chapter presented in the thesis is work in progress. The role of 
the first four transmembrane helices in PIB-ATPases is not known. In P2 and P3 
ATPases, the helices 1 to 5 undergo important conformational changes on metal 
binding. Loss of these helices in ZntA leads to very low activity of the pump and 
also the metal binding stoichiometry is reduced to 0.5. Further studies such as 
determining the Pb2+, Cd2+ and Zn2+ binding affinities for Del231-ZntA by 
competition titration experiments and determining the metal binding ligands in 
this mutant, will provide details regarding the role of these helices. Our results 
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may be able to provide an indication about the biological function of PINA, the 
splice variant of the Wilson Cu+-ATPase. 
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ZntA from Escherichia coli is a member of the P1B-type ATPase family of 
transporters. The P1B-type ATPase pumps maintain cellular homeostasis of 
heavy metals such as Zn2+, Co2+, Cu2+, Cu+, and mediate resistance to toxic 
metals such as Pb2+, Cd2+ and Ag+. ZntA confers resistance to Pb2+, Cd2+ and 
Zn2+ by pumping these ions out of the cytoplasm. ZntA has two metal binding 
sites, one in the hydrophilic N-terminal domain and the other in the 
transmembrane region. The cysteine-rich N-terminal domain has ~110 amino 
acids and the conserved motifs –CCCDXXC- and –DCXXC-. The role of these 
motifs in metal-binding specificity was determined by site-specific mutagenesis, 
metal-binding studies, functional assays and EXAFS. Our results show that both 
motifs play a role in metal binding and conferring the broad metal selectivity 
shown by ZntA.  
The N-terminal domain and the N-terminal metal-binding site are not 
essential for activity, but increase the kinetics of the pump and therefore, confer 
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a survival advantage to the organism. The transmembrane metal-binding site is 
essential for functioning of the pump. We investigated the role of the N-terminal 
metal-binding site in the overall function of the pump, and any possible 
interactions with the transmembrane site. Our results show that the isolated N-
terminal domain is capable of transferring its bound metal ion to both wtZntA and 
to a ZntA mutant lacking the N-terminal domain. Activities obtained with the 
metal ion bound to the N-terminal domain are much higher than when the metal 
ion is present as low-affinity complexes in the assay buffer. Together with metal 
binding affinities of the two sites, these data show that the N-terminal metal site 
is capable of transferring metal ions directly to the transmembrane metal site. 
Thus the N-terminal domain acts as a metal chaperone to the transport site in 
this class of pumps. The function of this “attached” chaperone appears to be to 
increase the rate of metal binding to the transmembrane site and thus increase 
the overall kinetics of the pump.  
In the last chapter, our studies on a truncated form of ZntA (Del231-ZntA), 
which lacks the first four transmembrane helices, are presented. This truncated 
form was based on the natural PINA splice variant of the copper-transporting 
Wilson disease-associated protein. Del231-ZntA had very low in vitro activity but 
was able to bind metal ions with a stoichiometry of 0.5, instead of the expected 
1. 
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